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1INTRODUCTION
This thesis is divided into two parts. The first part involves the new solvency directive for
the insurance industry in the European Union, Solvency II, which will be implemented
in 2012. The second part involves valuation strategies under the new directive.
First, I will investigate the concept of solvency and introduce the current solvency di-
rective, the Solvency I directive. Then I investigate the Solvency II directive especially
for life insurance undertakings within the European Union, which Norway have agreed
to follow. I describe the technical specifications of the Solvency II directive, including
its definitions and formulas, and discuss modifications which have to be implemented
for Norwegian life insurance undertakings. The goal of the new directive is to achieve
stability for the financial system. This shall be done by having enough buffer capital
on hand to cover expected and unexpected losses. The insurance industry has had its
deal of problems throughout the financial crisis. Factors include poor growth in the
stock market, and low interest rates which in turn have eaten up a large part of their
buffer capital. We therefore see a need for stricter requirements and regulations of the
industry.
The Solvency II directive requires that the undertakings valuate both the asset side, and
liability side in a market consistent way. The second part of the thesis starts out by
explaining the cash flows involved in life insurance. I continue by discussing different
risk neutral discount factors which are mentioned in the Solvency II directive. I then
introduce a method of achieving a market consistent valuation of both the asset side, and
the liability side. This method links the insurance cash flow to financial instruments.
Then by finding the market values of the financial instruments one can find the value of
the insurance portfolio. I look at a numerical example, to show this valuation method
in practice. In the end I introduce two asset liability management strategies which can




Solvency is an old concept. According to the Miriam-Webster Dictionary solvency orig-
inates from ca. 1727 as
the quality or state of being solvent.
A company is regarded solvent if it is
able to pay all its legal debts [by the mature date].
If the solvency of a company is good, it has financial strength. If on the other hand
a company is insolvent, the company can no longer operate and files for bankruptcy.
We will only consider insurance companies. An insurance company’s legal debts are its
expected insurance liabilities. Therefore a company needs to hold assets which covers
these liabilities. If the company invests in financial instruments it will have to hold
assets to cover the risk carried from the financial investments as well. The definition of
financial risk is the probability of unfavorable events, e.g. the probability that the actual
return becomes less what is expected return. The capital buffer needed for a company to
become solvent is called the solvency requirement. The big questions regarding solvency
of a company are:
• How large should the solvency requirement be?
• What time horizon should one consider?
• What kinds of assets can be used to cover the solvency requirement?
For regulatory system purposes these questions are answered both in the Solvency I and
again in the Solvency II directive. The answers in the two directives are designed to
minimize the likelihood of failure, while minimizing the costs to policyholders in the
event of failure. They are not a “zero-failure” regime. It is not realistic to build such
a system where we can guarantee that no insurance undertaking will ever fail. The
insurance undertakings would have to hold unlimited capital in order to cover extremely
unlikely, yet devastating event. The protection comes at a cost, the higher the level of
9
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guarantee, the higher the cost to he policyholders and the economy as a whole. Therefore
a balance has to be struck to offer affordable and safe insurance products.
2.1 Purpose of solvency
The purpose of solvency is to enable the investor to tell whether a company can pay its
debts or not. As the insurance companies are growing into large investors, their financial
strength is becoming very important for the soundness of the entire financial market. The
International Association of Insurance Supervisors (IAIS) is an organization which works
to promote financial stability and the development of well-regulated insurance markets.
They were established in 1994, and represents insurance regulators and supervisors in
nearly 140 countries. The IAIS defines solvency as:
the ability of an insurer to meet its liabilities under all contracts at any time.
Due to the very nature of insurance business, it is impossible to guarantee
solvency with certainty. In order to come to a practicable definition, it is
necessary to make clear under which circumstances the appropriateness of
the assets to cover claims is to be considered
The capital buffer must consist of free assets which can be realized within reasonable
time.
2.2 Solvency I
The Solvency I directive is the current solvency directive used by the insurance under-
takings of the EU member states. Solvency I is from 2002 and consists of 74 articles.
The solvency requirement in this directive is formed to ensure that an insurers’ capital
can act as a buffer against adverse business fluctuations.
The Solvency I consist of two capital requirements for life insurance. The Available
Solvency Margin (ASM) shall consist of the assets of the insurance undertaking free of
any foreseeable liabilities. It does not specify how to valuate the assets. This is left for
each member state to decide. The Required Solvency Margin (RSM) is in the robust
form
RSM = 4% of market risk
+ 0.3% of technical risk (2.1)
Market risk is the risk carried from the investment portfolio in the financial market, e.g.
the risk of changes in stock prices or interest rates. Technical risk is also called insurance
risk and arise from using the wrong claim rates e.g. the mortality rates may be incorrect.
The solvency rules in the Solvency I directive are simple, and rule-based. This makes
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the rules easy to understand, but do not take into account what kinds of businesses that
is written, and neglect differences between the asset and liability profile.
Already during the forming of the Solvency I directive it was concluded that further
attention had to be placed on the developments in the financial service industry. The
working group that proposed Solvency I suggested that
it may be desirable to undertake a wider review of the EU solvency re-
quirement system and to consider whether more explicit recognition of the
different risks is required
Their further work developed into a new solvency directive, Solvency II. Switzerland
chose a different approach, and adopted a risk-based capital system for the solvency
requirement on their own initiative. Current Norwegian requirements for solvency can
be found under www.lovdata.no1, and follow the regulations of the current EU direc-
tive.
1Forskrift om beregning av solvensmarginkrav og solvensmarginkapital for norske livsforsikringssel-
skaper from 1995, §3 and §4.
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Solvency II is a new set of regulatory requirements for insurance undertakings that op-
erate in the EU. The motivation for EUs insurance legislation is to ease the development
of a Single Market in insurance services in Europe, while at the same time securing
an adequate level of protection. The Solvency II directive has been in development for
quite some time. There is still a lot of work to be done before the new directive is imple-
mented. But the framework of the directive was approved at the EU parliament April
22 2009 and the final text adopted by the Council November 10 2009. When I started
writing this thesis the final Solvency II directive had not yet been stated. Nevertheless I
have described and commented on the framework of the directive and assumed that the
final text would not differ a lot from the framework. Fortunately my predictions were
correct.
The Solvency II directive consists of several old directives merged to one and includes
more than 300 articles. As the commission states,
the new directive is a recast, not a complete rewriting.
Even though about half of the articles of the new directive remains unchanged, the
most central articles are altered. These central articles include capital requirements,
solvency requirements and asset management. There is also new requirements concerning
governance and supervision, internal assessment of risk and solvency, capital add-ons and
public disclosure of information.
3.1 History
In the past years there have been a number of failures and “near misses” in the European
finance industry. A group of supervisors investigated these incidents between 1996 and
2001, and described cause-effect mappings and diagnostics for a total of 21 cases. A
report was made in 2002 called the Sharma report. The conclusions were that a solvency
13
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directive should include requirements for governance and risk management within the
companies, and the undertakings should build tools to monitor and mitigate risks at all
levels. In most of the studied cases, there was a chain of multiple underlying causes for
failure. So, the report stated that
Capital is only the second strategy of defense in a company, the first is good
risk management
The new Solvency II directive is, as we shall see, risk adjusted and based on a market
consistent valuation of both assets and liabilities.
Even before the financial crisis burst out, some companies, including insurance undertak-
ings, already concluded that the current requirements in the existing solvency directive
were insufficient. Some even implemented their own reforms. For example, in Switzer-
land the Swiss implemented their own Swiss Solvency Test and demanded that all Swiss
insurance companies comply with it. The Swiss Solvency test is similar to EU’s Solvency
II directive, and is so thorough that Switzerland is not going to implement EUs new sol-
vency directive. The implementation of own reforms throughout Europe has lead to a
patchwork of regulatory requirements. This hinders EU’s intent of developing a Single
Market.
The new Solvency II rules will replace all the old requirements, and apply to all insurance
undertakings by the end of October 2012. Norway has agreed to follow the Solvency II
directive.
3.2 Goals
The goal of the Solvency II directive is to protect policyholders, and the stability of
the financial system as a whole. It encourages undertakings to measure and manage
their own risk. It defines the quality of assets, and the minimum amounts of financial
resources insurers must have to cover liabilities and risks. Actuaries now must look at
the “total balance sheet”, instead of just concentrating on technical risk. In order to
do so they should valuate both assets and liabilities by a common market value. In
addition to managing their own risk, insurers are required to disclose key information
to supervisors and market participants. This leads to an early warning system, where
supervisors will have more time to make demands to improve and restore a companys
financial health.
3.3 Main points
The Solvency II directive is inspired by the Basel II accord from the banking industry,
which was introduced in 2006.
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3.3.1 The Pillars
As the Basel II accord, the Solvency II directive is formulated in three main pillars.
Pillar 1 focuses on the quantitative capital requirements. Pillar 2 focuses on the quali-
tative requirements such as a supervisory review process. Pillar 3 focuses on disclosure
requirements and greater market discipline.
3.3.1.1 Pillar 1
The first pillar specifies two financial requirements needed to obtain solvency, the Sol-
vency Capital Requirement (SCR) and the Minimum Capital Requirement (MCR).
The SCR reflects the capital an insurance undertaking must have available to cover
all its risks. The SCR can be determined either by the European Standard Formula
which I will elaborate on later, or by an internal model approved by the local financial
supervisory authorities (FSA). Companies are encouraged to develop internal models,
to improve their own risk management and governance depending on how they assess
the risks. The internal model might decrease the capital requirements. They might also
cause an even higher capital requirement than that of the standard formula.
The MCR is an absolute lower capital requirement. It corresponds to the RSM of
the Solvency I directive. This requirement constitutes a basic trigger mechanism for
ultimate supervisory action, which leads to closure to new business or withdrawal of
authorization.
One of the consequences of the pillar 1 is that insurers now are allowed to invest in any
asset they wish, provided that they can demonstrate that they understand the underlying
risk involved, and have capital enough to carry the risk.
3.3.1.2 Pillar 2
The second pillar specifies requirements for good internal risk management. The insurer
should have an internal assessment process for their assets, and show that they under-
stand the financial instruments their assets are invested in. The insurer must also have
strategies to manage the risks they are subject to. The risks involved will now include
market risk, credit risk and operational risk.
• Market risk is the fall in the value of insurers’ investments on the financial market.
• Credit risk is also called the default risk, and is the risk that third parties are
unable to repay their debts to the insurer.
• Operational risk is the risk of losses resulting from inadequate or failed internal
processes caused by people, systems and from external events.
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These are all risks that are not thoroughly covered by the current EU regime. The
insurance underwriting risk, also called technical risk, is the risk that the premiums will
not cover the future incurred losses such that the current reserves are insufficient. In life
insurance longevity is an example of an underwriting risk the insurers must be aware of,
i.e. that the population lives longer than expected.
3.3.1.3 Pillar 3
The Solvency II directive requires that the participating countries appoint a financial
supervisory authority that can evaluate the internal governance system and the capacity
of the management of the country’s insurance undertakings. In Norway the financial
supervisory authority will be represented by Finanstilsynet. Pillar 3 obligates firms to
disclose key information publicly. This enables supervisors to evaluate the information
and require adjustments where necessary so that policyholders can feel reassured. This
disclosure also provides every competitor with key information about the other com-
panies in the industry, a fact that was probably not the intent of the directive. The
main reason of reporting to supervisors is that they can identify insurers who might be
heading for difficulties. The supervisors should then have the proper power and means
to take preventive and corrective measures to ensure that the undertakings comply with
the requirements of the directive.
3.4 Valuation
The Solvency II risk-based philosophy for determining solvency capital requirements aims
to take account of all potential risks faced by the insurance undertakings. This includes
insurance, market, credit and operational risk. In line with the directive proposal, this
assessment should be made using an economic, market-consistent valuation of all assets
and liabilities.
This implies that whenever it is possible, the undertaking shall use the fair value, called
the mark-to-market method, for valuation. This involves decomposing the liability cash
flow into units and linking them to financial instruments. In that way one can use the
current arbitrage free market price for the instrument to valuate the liability cash flow.
I will explore this valuation method further in chapter 7.
If it is not possible to use a fair-value method for valuation, a mark-to-model method
should be used. This can for example occur in incomplete markets where there simply
does not exist replicating strategies for liabilities. To replicate the liabilities means to
construct a portfolio with the same value using instruments from the financial market.
The mark-to-model method is defined as any kind of valuation which has to be bench-
marked, extrapolated or otherwise calculated from a market model rather than market
prices.
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The SCR shall be calculated so that it is able to cover all losses with a confidence level
of 99.5%. To calculate the SCR it is therefore necessary to find the risk for losses both
from the insurance side and from the financial investments involved in the company’s
liabilities. A detailed explanation of the calculation of the SCR is described in section
3.6.2.
3.5 Technical provisions
Technical provisions are defined as the capital needed to meet the obligations the com-
pany has towards the policyholders of insurance contracts. Article 75 in the directive
states that
the value of technical provisions shall correspond to the current amount in-
surance and reinsurance undertakings would have to pay if they were to
transfer their insurance and reinsurance obligations immediately to another
insurance or reinsurance undertaking
The technical provisions are further divided into two elements, the discounted best esti-
mate cash flow, and a risk margin.
3.5.1 Best estimate
The discounted best estimate cash flow is the discounted probability-weighted average of
the future cash flow of claims and expenses, using the relevant risk-free interest rate term
structure. Under the Solvency II directive the risk-free interest rate is to be computed
by the swap rate. If there does not exist a swap rate market, government bonds are
to be used. The calculation of the best estimate cash flow should be based on current
information and realistic assumptions, and be performed using adequate actuarial and
statistical methods. The best estimate cash flow projection should take into account all
the cash flows required to settle the obligations over a lifetime. I will elaborate on this
calculation in chapter 5.
3.5.2 Risk margin
The risk margin is the extra capital which ensures that the technical provisions are
equivalent to the capital another insurance undertaking would require in order to take
over all of the undertaking’s obligations. In the Solvency II directive the risk margin
capital is equal to the cost of providing the amount of eligible own funds needed to
support the insurance obligations over their lifetime.
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3.5.3 Valuation of the technical provisions
According to Groupe Consultatifs Solvency II Pillar I working group, the technical provi-
sions would ideally be established as the best estimate discounted reserves plus a market
value margin based on the market cost of hedging, see chapter 9. The Groupe Consul-
tatif’s purpose is to bring together the actuarial associations in the EU to represent the
actuarial profession in discussion with the EU’s institutions on EU legislation which has
an impact on the profession.
The best estimate and the risk margin are to be valued separately. The exception
is when the future cash flow associated with insurance obligations can be replicated
using financial instruments for which market values can be found. If so the value of
the technical provisions should be determined by the market value of those instruments
comprising the technical provisions.
3.6 SCR and MCR
The Solvency II directive is principle-based which means no formulas are included di-
rectly in the directive. The formulas are only supplemented in consultation papers. The
consultation papers provide a standard formula for the overall SCR for the undertaking.
In addition they define capital charge, or SCR, for operational risk as well as a correlation
table between the capital charges for the five main risk categories namely market risk,
life underwriting risk, counterparty default risk, health underwriting risk, and non-life
underwriting risk. The capital charge is the amount of capital they are required to have
to support each risk module. The consultation papers also provide definitions, formulas
and correlation tables for sub-modules within these five main risk categories.
But before we look at the calculation of the SCR and MCR let us look at the relationship
between the capital requirements from the Solvency I directive and the Solvency II
directive.
3.6.1 Relation between the capital requirements in Solvency I and Sol-
vency II
The undertaking must have assets to cover the liabilities. Under the Solvency I directive,
the capital requirement an undertaking needed to have in order to run the business was
the Required Solvency Margin. This requirement has been divided into two different
capital requirements in the Solvency II directive. In the new directive, the lower, and
absolute minimum requirement is the Minimum Capital Requirement. It is calculated
quite differently from the RSM in the Solvency I directive, see 2.1 and 3.2. The SCR is
another capital requirement for the Solvency II directive established to help the super-
visory authorities regulate the industry. This requirement is set higher than the RSM of
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the Solvency I directive. An illustration of the different capital requirements belonging
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Figure 3.1: Relationship between the capital requirements
3.6.2 Calculation of the SCR and MCR
The SCR is calculated either with the standard formula given by the directive, or by
an internal model. Both formulas are to be based on a Value at Risk measure (VaR) of
the insurance liabilities calibrated at a 99.5% confidence level over a one year period. A
VaR-measure is a commonly used risk measure and is used to measure the risk of loss on
a specific portfolio of assets or liabilities. It measures the worst expected mark-to-market
loss under normal conditions over a specific time period at a given confidence level. A
99.5% VaR over one year reflects the worst loss one would expect to occur in a single
year, with the expectation that such a loss only happens one year in 200.
The MCR is not fully risk-based. It is calculated either by the standard formula with
a VaR calibrated to a 85% confidence level over a period of one year, or by a tunnel
between 25-50% of the SCR.
MCRdef = min(max(MCR85%V aR, 0.2 · SCR), 0.5 · SCR) (3.1)
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The confidence level approach is preferred by the industry for its simplicity, and provides
an adequate ladder of intervention under the QIS 3 exercise. However, since it is not
independent to the SCR it is considered that it does not provide a suitable ‘safety net”.
The tunnel approach, on the other hand, has been criticized for not being sufficiently
risk sensitive, it appears to be an evolution of the Solvency I approach. There is no
consideration of the firm’s risk posed by the assets it holds.
The MCR absolute minimum, MCRabs, is 2.2M EUR for non-life insurance, and 3.2M
EUR for life and reinsurance
MCR = max(MCRdef ,MCRabs). (3.2)
The MCR is to be computed quarterly, but the SCR annually. But since the MCR is
dependent on the SCR, in reality both will have to be computed quarterly. In addition
the capital requirements shall be computed again when the undertaking experiences
changes in their risk profile.
3.6.3 Expected shortfall vs value at risk
Throughout the Solvency II directive, value at risk has been the chosen risk measure.
The problem with the VaR measure is that it is not convex, i.e. it does not take into
account the diversification effects of financial positions. An alternative risk measure
which would be better to use is the expected shortfall. It can for example be used in
internal models. In contrast to the VaR measure the expected shortfall measure takes
convex risk measure diversification effects into account. The expected shortfall is more
sensitive to the shape of the loss distribution in the tail of the distribution. Where the
value at risk measure asks ‘how bad can things get”, the expected shortfall risk measure
asks “if things go bad, how much can we expect to loose”. The expected shortfall
is the expected loss over one period conditioned on the fact that we are in the (100-
X)% left tail of the distribution. The value at risk is used as the risk measure in the
Solvency II directive since it is easy to understand and to implement. The expected
shortfall is however not much more complicated, and is an even more conservative risk
measure.
3.7 Standard Formula
The European Standard Formula is a basic calculation method that insurers can use to
determine their overall SCR. The structure of the formula is set but the final calibration
of the parameters are still in the testing phase. The aim of the standard formula is to
differentiate and quantify each risk, i.e. market risk, credit risk, underwriting risk and
operational risk. The parameters will be available at least 12 months before the insurers
need to start applying the new rules. I will comment on how the standard formula is as
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described in the QIS 4 Technical Specifications. QIS 4 is the latest of the quantitative
impact studies which have been held. The studies are used to calibrate the parameters
of the Solvency II directive, see section 4.1.
The overall SCR, or capital charge, for an undertaking is defined as
SCR = SCROP + BSCR−Adj (3.3)
where
• SCROP = The capital charge for operational risk, which is the risk of loss arising
from failed internal processes, people or systems. In other words, risk arising from
human errors. Operational risk also include legal risk. It tries to address all risks
which are not covered in the other risk modules, such as financial risk.
• BSCR = The basic SCR before adjustments, combining capital charges for the five
major risk categories
• Adj = The sum of the adjustment for risk absorbing effect of future profit sharing
and adjustments for risk absorbing effect of deferred taxes.
The capital charge of operational risk is calculated by
SCROP = min(0.3 · BSCR,OPnot ul) + 0.25 · Expul (3.4)
where OPnot ul refers to the basic operational risk charge for all business other than
unit-linked business and Expul is the amount of annual expenses incurred in respect of
unit linked business. A unit linked insurance plan is a financial product where the policy
value at any time varies according to the value of the underlying assets at the time. In
other words, it offers both a life insurance as well as an investment such as a mutual
fund. In unit linked businesses, the policyholder carries the financial risk of self chosen
investments. Equation (3.4) restricts the SCROP to a percentage of the other capital
requirements included in the BSCR.




CorrSCRr,c · SCRr · SCRc (3.5)
with CorrSCRr,c corresponding to the cells of the correlation table 3.1. The SCRr
and SCRc corresponds to the the capital charges for the individual risks which I will
discuss below. The correlation parameters are subject to change before Solvency II
implementation, but as of now they are as follows1
1The correlation matrix is symmetrical
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Corr SCR SCRmarket SCRdefault SCRlife SCRhealth SCRnon life
SCRmarket 1
SCRdefault 0.25 1
SCRlife 0.25 0.25 1
SCRhealth 0.25 0.25 0.25 1
SCRnon life 0.25 0.5 0 0 1
Table 3.1: Correlation table for overall SCR
Not all of the individual risks are relevant to life insurance, but the SCRmarket, SCRdefault
and the SCRlife are. I will describe these individual risks from the overall SCR. The
parameters are determined to calibrate the VaR of the overall SCR to a confidence level
of 99.5%.
3.7.1 Market risk
The market risk is the risk that arises from the volatility of the market prices of financial
instruments. Examples of market risks are interest rate risk, equity risk, property risk,
spread risk, risk concentration and currency risk. All the sub-modules of the market
risk are determined so that the SCRmarket becomes the result of a stress test with all the
worst case scenarios happening at the same time. The worst case scenarios corresponds
to a defined shock to the net asset value minus all liabilities, NAV. That is to say the
immediate expected effect on assets and liabilities given the event of a shock. An example
of market risk arising from equity risk is
Mktequity = ∆NAV |equity shock (3.6)
Interest rate risk exists for all assets and liabilities for which the net asset value is
sensitive to changes in interest rates or interest rate volatility. These assets include
fixed-income investments, insurance liabilities and interest rate derivatives. The QIS
4 technical specification states that the undertakings should use the zero coupon swap
curve as interest term structure. A swap curve is constructed from interest rates at which
a fixed interest rate is swapped against the 6-month EURIBOR2 which is a floating
rate. It further states that the capital charge of the interest rate risk is determined by
the ∆NAV given an upwards or downwards stress factor, sup or sdown, to the current
interest rates. The altered term structures are given by multiplying the current interest
rate curve by (1 + s)up or (1 + s)down . The stress parameters are specified for individual
maturities. The capital charge for interest rate risk is derived from the shock that gives
rise to the highest capital charge.
Equity risk arises from the volatility of market prices for equities. Exposure to equity
risk refers to all assets and liabilities whose value is sensitive to changes in equity prices.
2European Interbank Offer Rate
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The equity risk module uses indices as risk proxies, meaning that the volatility and
correlation information is derived from these indices. The capital charge of equity risk
is defined as ∆NAV given a stress factor on all of the indices. The stress factor varies
between a 32% fall of equity indices listed in EEA3 and OECD4 countries, and a 40%
fall for all other equity indices. Due to the financial crisis however we observed a fall in
the indices in the first group of more than 40% in 2008.
The property risk is the risk that arises from volatility of market prices in the real
estate market. A worst case scenario is a fall in property prices compared to the real
estate benchmark. The capital charge for property risk is therefore the ∆NAV given a
20% decrease of the real estate benchmark.
The currency risk is the risk that the local currency will rise or fall respectively in
value against all other currencies. The capital charge of the currency risk is ∆NAV
given an upward or downward shock factor of 20%. The capital charge for currency risk
is the shock that gives rise to the highest capital charge.
Spread risk is the risk of changes in the market value of for example bonds caused
by changes in credit spreads. It reflects the change in the market value due to a move
of the yield curve relative to the risk-free interest rate. Unit linked contracts, where
the policyholder bears the investment risk, should be excluded from this module. The
capital charge of the spread risk is given by the formula∑
i
MVi ·m(duri) · F (ratingi) ·∆Liab (3.7)
This formula include
• MVi which is the credit risk exposure determined by reference to market values.
• m(duri) which is a function of the duration depending on rating class AAA-
Unrated.
• F (ratingi) which is a function of the rating class itself, and gives the credit risk
exposure calibrated to deliver a shock consistent with VaR of 99.5%.
• ∆Liab which is the overall impact on the liability side when the policyholders bear
the investment risk.
Concentration risk arises from the additional volatility that exists in concentrated
asset portfolios and the risk of partial or total permanent losses of value due to the
default of an issuer. These parameters and functions are all included in the consulting
papers.
Now that all the sub-module risks of the market risk are explained we can define the
3European Economic Area
4Organization of Economic Co-operation and Development
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CorrMktr,c ·Mktr ·Mkrc (3.8)
where the correlation table for market risk is as in table 3.2, where Mktr and Mktc
corresponds to the the capital charges for the individual market risk modules discussed
above
CorrMkt Mktint Mktequity Mktprop Mktspread Mktconcentration Mktcurrency
Mktint 1
Mktequity 0 1
Mktprop 0.5 0.75 1
Mktspread 0.25 0.25 0.25 1
Mktconcentration 0 0 0 0 1
Mktcurrency 0.25 0.25 0.25 0.25 0 1
Table 3.2: Correlation table for market risk
3.7.2 Counterparty default risk
Counterparty default risk is the risk of possible losses due to an unexpected default or
deterioration in the credit standing of counterparties in relation to risk mitigating5 con-
tracts. Default can occur in reinsurance arrangements and derivatives and the estimated
losses are to be computed separately. The estimated loss given default of reinsurance
contracts is given by
LGD = 0.5 ·max(Recoverables + SCRGrossU/W − SCRNetU/W − Collateral, 0) (3.9)
where
• Recoverables is the expected amount of recoverable capital from the reinsurance
contract
• SCRGrossU/W is the SCR for underwriting risk calculated by the standard formula, see
section 3.7.3
• SCRNetU/W is the SCR for underwriting risk according to the standard formula dis-
regarding the risk mitigating effect for the reinsurance contract
• Collateral is the collateral covering the loss in relation to the counterparty
The 0.5 factor takes into account that the defaulter always will be able to meet a large
part of its obligations.
5risk reduction
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The estimated loss given default in derivative contracts is given by
LGD = 0.5 ·max(Market value + SCRGrossMkt − SCRNetMkt − collateral, 0) (3.10)
where
• Market value is the market value of the financial derivative
• The SCRGrossMkt and SCRNetMkt are the SCRs according to the standard formula with
and without regarding the risk mitigating effect from the derivatives of the coun-
terparty
The counterparty default risk requirement Defi for exposure i is based on the Vasicek
distribution and is defined by









depending on the implicit correlation R









N is the cumulative distribution function for the standard normal random variable, and
G the inverse of N. PDi is the probability of default for counterparty i. The capital





3.7.3 Life underwriting risk
The life underwriting risk includes mortality risk, longevity risk, and disability risk. It
also includes lapse risk which is the risk of termination of policies, as well as revision
risk and catastrophe risk. The underwriting risk modules are stress tested and summed
up, such that all the worst case scenarios from the sub-module risks happen at the same
time.
Mortality risk reflects the uncertainty in trends and parameters in the current mor-
tality rates that are not already included in the valuation of technical provisions. It
calculates the ∆NAV given an increase in the mortality rate of 10% for each year. The
mortality risk will then be stress tested by an unfortunate event. To get the capital
charge of the mortality risk we sum up the ∆NAV s over all the policies where the
payment of benefits is dependent on the mortality risk.
Longevity risk is the risk that the population lives longer than expected. It calculates
the ∆NAV given a decrease in mortality rates of 25% for each year. To find the capital
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charge we sum up the ∆NAV s over all policies where benefits depend on longevity
risk.
Disability risk reflects the risk of uncertainty in parameters in disability rates that are




∆NAV |disability shock (3.14)
where the disability shock is given by an increase of 35% in disability rates for the
next year together with a 25% increase in disability rates at all ages in the following
years.
Lapse risk is the risk of change in the insurance liability which occur if the policyholders
terminate their policies or don’t pay their premium.
Lifelapse = max(Lapseup,Lapsedown,Lapsemass) (3.15)





The lapseshockup/down corresponds to an increase or reduction of 50% of the assumed
rates of termination in all future years for policies where the termination strain, the dif-
ference between the amount currently payable on termination and the expected amount
of provision held, is expected to be positive or negative respectively. The lapseshockmass
is defined as 30% of the sum of surrender strains over the policies where the surren-
der strains are positive. The result reflects the loss which is incurred in a mass lapse
event.
Expense risk reflect the variation in expenses incurred in servicing the insurance and
reinsurance contracts. The capital charge of the expense risk is
Lifeexp = ∆NAV |expense shock (3.17)
The expense shock corresponds to a 10% increase in future expenses compared to our
best estimate and a 1% increase per annum of the expense inflation rate compared to
anticipation.
Revision risk is meant to capture the risk of adverse variation of an annuity’s amount
as a result of an unanticipated revision of the claims process. LifeRev is defined as ∆NAV
given an increase of 3% in the annual amount payable for annuities exposed to revision
risk.
Catastrophe risk tries to capture extreme and irregular events which are not captured
in any of the other underwriting sub-modules. LifeCat is defined as ∆NAV given that
two events occur simultaneously. The first being a 1.5 per mille increase in the rate of
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policyholders dying within the following year. The second being a 1.5 per mille increase
in policyholders experiencing morbidity over the following year.
Now that all the sub-modules of life underwriting risk are explained we define the capital




CorrLifer×c · Lifer · Lifec (3.18)
where Lifer and Lifec corresponds to the capital charges for the sub-models of life under-
writing risk described above according to the rows and columns of the correlation table
CorrLiferxc from table 3.3.
CorrLife Lifemort Lifelong Lifedis Lifelapse Lifeexp Liferev LifeCAT
Lifemort 1
Lifelong -0.25 1
Lifedis 0.5 0 1
Lifelapse 0 0.25 0 1
Lifeexp 0.25 0.25 0.5 0.5 1
Liferev 0 0.25 0 0 0.25 1
Lifecat 0 0 0 0 0 0 1
Table 3.3: Correlation table for life underwriting risk
3.8 Internal model
Undertakings have the possibility of using their own internal model for the calculation
of the solvency capital requirements instead of the standard formula. This can either be
done through a partial or a full model. The internal model must, however, be calibrated
so that the confidence level objective of a 99.5% VaR over one year is fulfilled. It is not
required to implement an internal model but undertakings are encouraged to do so since
it will give them even better risk assessment, and might reduce the capital requirement.
The internal models must be approved by the local FSA before implementation.
3.9 Warning system
A Solvency II goal is to establish an early warning system, and allow more time for
supervisory intervention. Table 3.4 represents an adequate ladder of intervention for the
two capital requirements:









No Breach (Adequate Capital) Not Required Not Required Not Required Not Required
Breach of Adjusted SCR Required Possible Not Required Not Required
Breach of SCR Required Required Possible Not Required
Breach of MCR Required Required Required Required
Table 3.4: Supervisory intervention
The adjusted SCR is defined as the SCR plus any capital add-ons to account for risks
which is not fully accounted for in the SCR. These add-ons can be imposed by the
supervisor and results in a higher capital requirement. This is to cover the deficiencies
in the risk profile of an undertakings business when calculating the SCR.
If a company’s capital breaches the SCR requirement the company is forced to improve
their financial strength and/or reduce the risk within the portfolio. If the capital is
under the MCR “ultimate supervisory action” will be triggered. This means that there
will be made plans to transfer the insurers liabilities to another company and the license
of the insurer will be withdrawn. In between these two requirements there exist steps
which represent degrees of supervisory interventions.
If an insurer is above the Solvency I requirement, but under the Solvency II require-
ment, they will have one year to comply with the MCR. This means by December 31.
2013.
3.10 Own funds
The main change from previous directives concerning solvency is that the free assets
now have to be of good quality as defined in the directive. The directive classifies the
quality of own funds into three tiers. They are classified as to how well and how fast
they absorb losses.
3.10.1 Tier 1
Tier 1 items are the funds that are available to fully absorb losses on an on-going basis,
as well as in the case of winding-up. Winding-up means to conclude business. It entails
selling all the assets of a business entity, paying off the creditors, and distributing any
remaining assets to the principals, before dissolving the business. For inclusion in Tier




Tier 2 items are the funds that in case of a winding-up, the total amount of the item is
available to absorb losses and the repayment of the item can be refused to its owner until
all other obligations have been met. To be able to be classified as Tier 2 any payment
from financial instrument has to be able to be deferred in times of stress until financial
position is restored.
3.10.3 Tier 3
Tier 3 items shall contain all funds which did not fall into the two other tiers.
In addition to these classifications funds shall be evaluated by their relative duration as
compared to the duration of the insurance obligations of the undertaking before deciding
which tier they belong to. Duration is a measure of the sensitivity of the price (the value
of principal) of a fixed-income investment to a change in interest rates.
3.11 Eligibility
To comply with the solvency capital requirement the eligibility of the funds are subject
to quantitative limits. There are two types of eligible own funds which together are the
total amount of eligible own funds. The first type comprise the economic capital i.e.
the excess of assets over liabilities. This is the eligible basic own funds. The other type
comprise the commitments that undertakings can call upon in order to increase their
financial resources i.e. letters of credit. This is the ancillary own funds.
Firstly the proportion of Tier 1 items shall be higher than one third of the total amount
of eligible own funds. Secondly the proportion of Tier 3 items shall be less than one
third of the total amount of eligible own funds.
As far as the minimum capital requirement is concerned there are quantitative limits as
well. Here the ancillary own funds are not eligible. The proportion of Tier 1 items must
be higher than one half of the total amount of eligible basic own funds.
The eligible amounts of own funds to cover the SCR is equal to the sum of the amount
of Tier 1 and the eligible amounts of Tier 2 and Tier 3. The eligible basic own funds
to cover the MCR should be equal the sum of the amount of Tier 1, and the eligible
amounts of basic own fund items classified as Tier 2.
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3.12 Solvency requirement figure
To ensure that we have enough assets, and to comply with the SCR of the Solvency
II directive, we calculate the VaR of insurance and financial liabilities with a 99.5%
confidence level. In addition to the technical provisions, an insurer will need to hold the
value of the SCR in good quality assets to comply with the directive. An illustration of















Figure 3.2: Illustration of solvency requirements
3.13 Conclusion
The Solvency II directive answers all the big questions regarding solvency. It defines how
large the solvency requirement should be, and how to calculate it. The time horizon to
considers regarding the solvency requirements is one year. The directive also states
which assets are eligible to cover the solvency requirement.
There is much work to be done with the implementation of the new directive. The
final parameters for the stress test and correlation matrices need to be set, and the final
quantitative impact study, QIS 5, has to be held.
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The directive has concentrated on improving the overall risk assessment of the companies.
The choice of the correlation parameters is however difficult to understand. It is not
explained how these parameters are chosen, only that they presumably give the wanted
99.5% VaR measure. The MCR calculation is also a little uncertain. As of now it is a
combination of two different approaches. I assume they will have to choose one of them,
and preferably the risk based alternative.
For the undertakings there are a lot of calculations to be done in order to find the new
solvency requirements. The undertakings will be required to report their calculations
to the supervisory authorities. This will involve new projects for the insurance under-
takings. Even more work if they decide to implement an internal model. However, if
the directive achieves its goals, it will help the undertakings to have control over their
financial situation and risks. It will also give the regulatory authorities the necessary
data for supervising the solvency of the insurance undertakings.
In the next chapter I will study the expected changes for the Norwegian life insurance
undertakings, and evaluate the QIS 4 study that has been run for these undertakings.
I will then continue by studying the valuation aspect of the directive. To be able to
calculate the solvency capital according to the Solvency II directive requirement we need
a “full balance sheet” approach. This means to measure both the assets and liabilities in
one consistent way. In order to do so we will use market values because of its switching
property. By using market values we can make arrangements to switch assets to cover
our liabilities at market price. It is therefore clear that we need a market-consistent
valuation, also called mark-to-market model, of the balance sheet. I will eventually
show how to construct a valuation portfolio that reflects a market-consistent actuarial
valuation.




The Solvency II working progress follows the Lamfalussy process, which is an approach to
the development of financial service industry regulation used by the EU. It is composed
of four levels, each focusing on a specific stage of the implementation of the legislative
process.
At the first level a legislation is adopted by the European Parliament and the Council
of the EU. The core values and building guidelines of the implementation is set. At the
second level supplementary sector-specific committees and regulators advise on technical
details. At the third level the Committee of European Insurance and Occupational Pen-
sions Supervisors (CEIOPS) develop harmonized standards across the member states.
CEIOPS consists of the European Union’s insurance and pension fund supervisory au-
thorities. The third level is where the Quantitative Impact Studies (QIS) are carried
out, see 4.1. At the fourth level, the new directive will be implemented.
By evaluating the QIS results for the Norwegian undertakings we can comment on a few
key modifications.
4.1 Quantitative Impact Studies
The European Commission is responsible for outlining the solvency directive. They
have received technical advice from the CEIOPS on legislative matters. CEIOPS has
in this regard supervised simulations on the preliminary proposal of the Solvency II
directive. These simulations are called quantitative impact studies. The QIS are a way
of testing out the parameters involved in the standard formula and the new requirements
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for financial capital. The QIS is conducted by insurance undertakings, and are done on
a voluntary basis throughout the EU. Up until now there have been conducted four
such studies, and the fifth will be conducted during the fall of 2010. The studies will
ensure that the final SCR formulas and parameters are calibrated correctly, such that
the capital requirement’s VaR is set at a confidence level of 99.5%. The final parameters
will be decided by the end of 2010. Then the companies can begin implementing the
Solvency II directive. The QIS 4 simulations used data as of December 31. 2007. The
simulations were run between April-July of 2008.
4.1.1 Norwegian result for life insurance undertakings
Results from QIS 4 show that 40% of the Norwegian life insurance companies partici-
pated. These companies have 92.3% of the market shares of participants. From the study
it turns out that under the new Solvency II requirements, the mean available capital to
SCR is 112%. Compared to the Solvency I requirements the mean available solvency
margin is 198%. Although these percentages are not directly comparable (see figure
3.1), it gives us a hint that the new directive requires more capital to avoid supervisory
interference. It implies that under the new directive companies might need to bring in
more capital, or take less risk in the form of selling out part of their stock portfolio and
buying bonds instead.
The market risk component is the most dominant risk in the SCR calculation with an
average of 87% of the BSCR∗ where
BSCR∗ = BSCR + SCROP (4.1)
In comparison the life underwriting risk accounts for an average of 28% of the BSCR∗.
The counterparty risk is negligible with 0.2%, and the capital charge of operational risk
amounts to 2.1% of the BSCR∗. The diversification effect due to correlation assumptions
between the risks mentioned is 17%.
The adjustment factor in the SCR calculation, see equation (3.3), is stipulated to be
more than 45% of the BSCR∗ on average. There is an ongoing discussion concerning the
different approaches being used to valuate future discretionary dividends to policyhold-
ers before and after stress. Therefore we observed variations in the adjustment factor
from 35-55%. Further specification in the implementing measures will have a significant
impact on the overall SCR.
Finanstilsynet considers making the participation in the QIS 5 mandatory for Norwegian
insurance undertakings. None of the Norwegian insurance companies reported SCR
calculations based on an internal model.
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4.2 Key modifications for Norwegian undertakings
The Solvency II directive will go through the Norwegian legislation by October 2012.
This implies that the new directive is to be applied for the fiscal year 2013. The prepara-
tion to follow the Solvency II directive will begin simultaneously with the implementation
of the new pension reform which is to be implemented in 2011. If the insurance under-
takings want to use an internal model, the preparation should begin even sooner. It will
lead to a lot of extra work in order to implement both the directive and the reform, and
undertakings should be prepared for this.
4.2.1 Governance and control
Companies will be required to carry out its Own Risk and Solvency Assessment (ORSA)
under the Solvency II directive which will be an integrated part of the operation of the
company. The ORSA is an internal assessment process within the undertaking. It is
also a supervisory tool for the supervisory authorities. The aim is to identify whether
the particular risk profile of an undertaking deviates from the assumptions underlying
the standard or internal model.
4.2.2 Valuation
Assets and liabilities shall be valuated using “realistic” values. This will lead to a change
in how the insurance liabilities is valued i.e. best estimate element plus a risk margin.
On the asset side, the held-to-yield bonds shall furthermore be valuated by its real value.
For accounting purposes the value of held-to-yield bonds are as of now determined by
the price it was bought for, the time to maturity, and its return. Under the new solvency
directive these bonds must be valued using the market price.
Maybe the most important change with the new directive is the use of a risk-free rate of
interest for discounting. As of now the discounted technical provisions are calculated by
using a fixed technical rate determined by Finanstilsynet. Switching to a risk-free interest
rate implies that the technical provisions will fluctuate with the interest rate.
4.2.3 Calculations of capital requirements
As stated above there are two new capital requirements, the SCR and MCR which have
to be calculated. There is also the possibility of developing full, or partly internal models
for the capital requirement. This model must be based on known risk measures, and be
calibrated with an equal VaR as the standard formula. It has to be validated, tested,
and documented. The insurance companies should have begun developing such models
by the beginning of 2010 to be able to implement it at the same time as the rest of the
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new directive. An internal model will have to be approved by Finanstilsynet before it
can be used to calculate the capital requirement instead of the standard formula.
4.2.4 Own Funds
The quality of the capital is broken down into three tiers as described in section 3.10.
Assets that entered in the required solvency margin of the Solvency I directive does
not necessarily enter into the solvency capital requirement of the Solvency II directive.
Stricter requirements to the quality of the assets might imply that the undertakings will
need to shift around their assets to meet the new requirements. It may also mean that
they need to bring in more capital to their asset portfolio.
4.2.5 Reporting
There will be new requirements for reporting to Finanstilsynet and the public both in
format and frequency. This includes a change in the existing reports such as actuar-
ial reports, and solvency margin reports. As of June 2009 Finanstilsynet requires the
insurance undertakings to perform a stress test quite similar to the standard formula
calculations of the Solvency II directive. These stress tests are to be handed in each
quarter.
5THE BEST ESTIMATE CASH
FLOW
In section 3.5 we defined an insurers technical provisions by the capital the insurer
would need to meet his obligations towards the policyholders. We also insisted that the
technical provisions equal the discounted best estimate of the companys cash flows plus
a risk margin. In this section we shall describe the cash flows involved in the insurance
industry, and how they are calculated. I will only consider cash flows which occur in
life insurance, and disregard the cash flows involved in the non-life insurance industry.
In life insurance the undertakings are liable either if the insured dies, or if he becomes
disabled. If the insured dies, there might be a spouse, a partner, a cohabitant or children
that are entitled to compensation. The compensation can either be a one-time payment,
or in monthly or yearly payments for a specific time period or until death.
5.1 Basic model
In order to define a model for calculating the best estimate cash flows I will discuss
the theory behind the basic discrete time model for a random cash flow. This model
will include concepts from probability theory. We assume we have a probability space
(Ω,F , P ) and an increasing sequence of σ-fields (Ft)t=0,...,n with
{∅,Ω} = F0 ⊂ F1 ⊂ · · · ⊂ Fn ⊂ F (5.1)
• Here ∅ denotes the empty set, Ω is the sample space that contains all possible
outcomes of the random experiment, F is a σ-field, and P (·) : F → [0, 1] is a
probability measure.
• In the present case of an insurers’ random cash flow, P(ω) > 0 for all ω ∈ Ω. Also
F0,F1, . . . ,Fn is an increasing sequence of sub-σ-fields of F that describes how
information about payments are revealed to the insurer.
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• We will think of the cash flow that the insurer faces as a sequence of Ft adapted
random variables X0, X1, . . . , Xn. Also, in this chapter, we will let X denote a
sequence of cash flows with Xi = 0 for i 6= t, and with a single payment of Xt at
time t.
In this chapter, our main goal will be to find the value of the cash flow X.
5.2 Cash flows
The best estimate cash flow from the Solvency II directive is a cash flow X, which
consists of several seperate cash flows. Let us first consider a policy in one specific time
period. The policyholders pay a premium, Πt at time t. This premium is calculated and
charged by the insurer and corresponds to the policyholders expected financial expenses
and benefits which the insurer is liable for. The insurer then pays the policyholders
for actually incurred expenses and benefits, Ct, within the time period (t - 1,t]. If we
assume that all the payouts occur at the end of the time period, the discrete cash flow,
X, at time t equals
Xt = −Πt + Ct (5.2)
It is not a requirement for the Xt to be negative at all times. However it is a requirement
that Xt is measurable with respect to Ft. Due to the fact that not all the liabilities are
settled at once, it is possible to generate income from investments on the premiums and
delayed settlements on the condition that you are able to meet your liabilities at all
times.
5.3 The best estimate cash flow model
It is impossible to know exactly how much an insurance undertaking is liable for in
claims and expenses each year. This is due to an unknown mortality and disability rate.
Because of this uncertainty we are satisfied by finding a best estimate for our insurance
liability cash flow. I will describe the calculation of this cash flow from the QIS 4’s
technical provisions definition.
The best estimate is equal to the expected present value of all future potential
cash flows (probability weighted average of distributional outcomes), based
upon current and credible information, having due regard to all available
information and reflecting the characteristics of the underlying (re)insurance
portfolio.
I will discuss the interest rate used to obtain the discounted best estimate cash flow in
the next sections, but first I want to find a realistic expression for the best estimate of
the cash flow at a given period t. To find the estimate we would begin by analyzing
historical data for disability or mortality rates, using statistical methods. Then we would
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need to find a distribution with parameters such that the incurred data for disability
or mortality rates fit. Fortunately this work has already been done for us. For the
Norwegian population parameters from either K2005 or GAP07 can be used. They are
prepared by FNH1 and Gabler Wassum AS respectively. They both offer mortality rates
as well as the probability of surviving spouse and children, and disability rates for both
men and women.
I will elaborate a bit on the mortality rate. The FNH parameters, which probably are
the most used parameters in Norway, use a Gompertz-Makeham mortality model with a
mortality rate equal to the sum of a constant, and an age-dependent component which
increase exponentially with age:
qx = 1− exp(θ0 + θ1eθ2x), (5.3)
where qx is the probability of death within one year given age x. The Gompertz-Makeham
model is pretty accurate for ages up to 100. For advanced ages however, it actually
predicts a too high mortality. The GAP07 therefore includes additional parameters









0.01 · x, if x ≤ 0
(0.01 · x)γ , otherwise (5.5)
A figure of the Norwegian mortality for men calibrated for the year 2004 is given in
figure 5.1. The equations (5.3) and (5.4) are used. The parameters are found in [3]. For
the Gompertz-Makeham rate they are θ = (−0.00309,−0.0000219, 0.100047). And for
GAP07 they are θ = (9.03984, 3.50737, 12.35429), x0 = 78 and γ = 0.93969.
It is important not to use the parameters uncritically, due to several sources of error
which we have to be aware of. The choice of parameters might not be the optimal in the
future, even though it was so in the past. This can cause estimation error. One issue is
that the population seems to live longer and longer. This should be picked up by the
new rates. Another problem is that the insured population might have a slightly higher
life expectancy than the population as a whole. Reasons for this could be
• Regional: there could be regional differences in mortality. There might not be the
same types of jobs available in the countryside as in the big cities. Traffic accidents
have a higher intensity in the cities.
• Ethnic: the population might include a higher number of immigrants than the
population as a whole. This group might have different life expectancies.
• Occupational: specific occupational groups are more physically demanding which
could cause higher disability rates. Other groups are more exposed to accidents.
And office jobs might be related to a higher life expectancy.
1Finansnæringens Hovedorganisasjon
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Figure 5.1: Gompertz-Makeham and GAP07 mortality curves
All of these factors could cause a drastically higher liability estimate. The errors men-
tioned above are in general called technical risk. There is a need to calibrate the mor-
tatility rates to our insurance portfolio, and we are left with an estimate for our best
estimate which is the expected value of expenses the company is liable for.
The expected best estimate cash flow will only be a prognosis of the real value because of
the technical risk, and we will therefore always have deviations from the true outcome.
In other words, if all parameters involved in the cash flow estimation could be determined
with absolute certainty, and the parties involved were risk-neutral, then the best estimate
value would equal the market value.
Our best estimate element described above needs to be discounted to find the best
estimate as stated in the Solvency II directive. It has been common practice in Norway
to discount the best estimate with a technical rate of interest, but when calculating
the market value of our liability cash flow it would be wise to use a market rate of
interest.
5.3.1 Technical rate
The Solvency II directive states that the best estimate cash flow is to be discounted
using a risk-free interest rate. As of now however, most contracts in Norway contain
an interest rate guarantee which the Norwegian regulators, Finanstilsynet, have defined.
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The rate has been chosen with respect to the EU life insurance directive2. The directive
states that the highest rate of interest should be determined with caution and not exceed
60% of the long-term government treasury bill rates. In Norway the longest government
bonds have a duration of 10 years. Taking the directive into account the maximum rate






at time t. Setting the rate of interest lower than the maximum rate will lead to increased
premium and lower interest rate guarantee for policyholders. Although the insurance
companies by law are enforced to use a constant discount rate when calculating premiums
and premium reserves it would be wise to calculate outcomes with a stochastic discount
rate as well. The advantage of using a constant discount rate is that it gives a consistent
and predictable theory, but it is not necessarily realistic compared to observed rates.
When converting to the Solvency II regime we should obtain rates that are consistent
with the financial market, i.e. the risk-free interest rate.
5.4 Discounting under Solvency II
QIS 4 states that all cash flows should be discounted using the risk-free discount rate
applicable for the relevant maturity at the valuation date. Where the market does not
provide data for maturity, extrapolation or interpolation shall be used. In QIS4 the
risk-free interest rate was derived from swap rates. If there did not exist a swap rate
market, government bonds were to be used. Where cash flows were linked to financial
instruments, the market values of the financial instruments were to be used. Hence, an
equation of the discounted value of the best estimate cash flow (φ ·X) at time t under
the real world probability measure P will look like
E(Xt) = E(φt ·X|Ft) (5.7)
where we condition on the information revealed at time t. I will discuss the use of zero
coupon bonds and swap rates as discount factors in chapter 6.
5.5 Conclusion
We have described a way of calculating the best estimate cash flow. We have also
discussed which interest rate we should use to discount our best estimate of an insurer’s
cash flow during a given period t. Under the new Solvency II directive, we shall make
use of the risk-free interest rate. We will discuss this stochastic discount rate further
in chapter 6. When discounting the best estimate cash flow, we shall make use of the
2Directive 2002/83/EC Article 20 No.1, B.(i)
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σ-field F that we described at the beginning of the chapter. The cash flow information
is revealed in accordance with Ft.
6STOCHASTIC
DISCOUNTING
Now we know how the best estimate of the cash flow pertaining to a given period is
calculated. For accounting purposes and in exchange with the regulator we want to be
able to discount our best estimate cash flow. The QIS 4 specifies different alternatives
which can be applied. We want to find a discount factor, or numeraire, which transforms
our cash flow into a fair value, which implies an arbitrage free valuation.
6.1 Arbitrage-free valuation
In this chapter we consider the same insurance company that we discussed in chapter 5.
In particular, we assume that the company’s best estimate cash flows can be represented
by random variables on a probability space (Ω,F , P ), that are adapted to an increasing
sequence F0,F1, . . . ,Fn of sub-σ-fields of F . In chapter 5 the best estimate cash flow,
X, was an (n+1)-dimensional vector of the form (0, . . . , 0, Xt, 0, . . . , 0). In this chapter
X = (X0, . . . , Xn). To handle such cash flows, we assume that we have a function
Qt : L2n+1(P ) → R which is a positive, continuous, linear function in L2n+1(P). We
then define a mapping of the best estimate cash flow X 7→ Qt(X), which represents the
discounted monetary market value Qt(X) 7→ R of the cash flow X at time t.
We wish to consider a market without arbitrage opportunities. This is a market where
there does not exist a risk-less way of making money. Up until now we have operated with
a “real world”-probability measure, P. We need to introduce the definition of martingales,
and a risk neutral probability measure P ∗. The fundamental no arbitrage theorem
states that there are no arbitrage opportunities if and only if there exists a risk-neutral
probability measure.
Let us begin by defining martingales. Let Yt, t = 0, 1, . . . , n be a sequence of random
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variables on (Ω,F , P ), and let F0,F1, . . . ,Fn be the given increasing sequence of sub-σ-
fields of F . Then Yt is a martingale if
• Yt is Ft-adapted
• E[|Yt|] <∞ for all 0 ≤ t ≤ n
• E[Yt|Fs] = Ys for all 0 ≤ s ≤ t
• The Brownian motion is a martingale. E[Bt|Fs] = Bs for all 0 ≤ s ≤ t
A Brownian motion is a stochastic process on (Ω,F ,P) where
• B0 = 0
• the increments are independent such that Bt2 − Bt1 is independent of Bt3 − Bt2
for 0 < t1 < t2 < t3.
• the increments follow a normal distribution, i.e. Bt2 −Bt1 ∼ N (0, t2 − t1)
Now let us define a risk neutral probability measure for our insurer’s cash flows on
(Ω,F , P ). Suppose that
• P ∗ is a probability measure with strictly positive mass to every state Q(ω) ∈ Ω
• the discounted cash flow price (φt ·Xt) is a martingale under P ∗ for t ∈ (0, . . . , n).
Then P ∗ is a risk neutral probability measure, also called a martingale measure. If we
can prove that there exist a P ∗, then we have found a risk-neutral valuation of our price
process. We will see that in a risk neutral world the expected price of a process evolve
according to Ft.
6.2 Discounting
The price process of our best estimate cash flow, Qt(X), can be expressed as an expec-
tation on the sum of the cash flow multiplied by a stochastic discount factor, φ, which
is called a deflator or numeraire.
By Riesz representation theorem there exists a vector φ ∈ L2n+1(P ) s.t. for all X in








φ is a stochastic discount factor. Be aware of the fact that we do not know a general
expression for the value of the discount factor, the theorem only states that a discount
factor exists.
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Let us look at two interesting properties of the discount factor. The first property is that
the positivity of the price process Q ensures positivity of φ. The other property, which
will be very useful in further calculation, is that we can choose φt to be Ft-adapted.




















Equation (6.2) holds for all X. By this reasoning we shall from now on assume that φt as
well as φ˜t is Ft-adapted. This means that we can construct a discount factor where we
know its value at time t. With φt we have found a direct link between the behavior of the
financial market and the Ft-adapted cash flow Xt. We shall assume that φ0 = 1.
6.3 Risk-free interest rate
A risk-free interest rate is an interest rate which can be obtained by investing in a finan-
cial instrument without default risk. There does not exist truly risk-free interest rates,
but we can find pretty good estimates. A fair value estimate uses market expectations
on future interest rates. An estimate could be short-term government bond rates like
US treasury bills. LIBOR1 and EURIBOR2 can also be used. A treasury bill can in
theory not default, because the government can print new bills to pay its debts. This will
however lead to devaluation of the currency used. LIBOR rates are the approximated
rates for a short-term borrowing rate of an AAA credit rated3 company. An AAA-rated





where r¯0 corresponds to the market interest rate i.e. the interest rate observed in the
market.
We need to be aware of two main risks that can affect a bond’s investment value. The
first is liquidity risk which is the risk of being unable to sell the instrument for cash at
short notice without significant costs. The other is market risk which includes interest
rate risk, equity risk and currency risk.
Another candidate to the risk free interest rate is the swap rate. The swap rate derives
from an interest rate swap which is an agreement between two counterparties where one
1London Interbank Offer Rate
2European Interbank Offer Rate
3Refers to the rating agency Standard & Poor’s best credit rating. The second best being AA. AAA
correspond to Aaa from the rival rating agency Moody.
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agrees to pay a fixed rate (the swap rate) and the other agrees to pay a floating rate.
The rates are pinned to a notional principal amount to decide the size of the cash flow
which will be exchanged between the counterparties. The floating rate to be used under
the QIS 4 specifications is the 6-month EURIBOR. The interest rate swap is constructed
so that no initial payment is made. This makes the market value of the swap equal to
zero. Equation (6.3) still holds where r¯0 now is defined as the swap rate.
According to QIS 4, further work will need to be conducted to see whether swap rates are
an appropriate benchmark to determine the risk-free interest rate term structure, once
liquidity considerations have been taken into account. But the swap rate has however
been used in the simulation studies carried out so far.
Our problem with using the market interest rate, r¯0 is that the rate is only known up
to a certain time. After that we need models to predict the real interest rates and bond
prices. Here
real interest rate = nominal interest rate− inflation rate (6.4)
The Black-Karisinsky model, the Vasicˇek model, or the Cox-Ingersoll-Ross can be used
to estimate the interest rate, see Lamberton and Lapeyre [10]
6.4 Risk neutral discounting
We let our discount factor in a discrete world follow equation (6.3). We have in other
words discounted the price process with a risk free interest rate. At time t the price
process Qt is given by conditioning on the σ-algebra F







In order for the price process to be risk neutral we have switched to the risk neutral
probability measure, P ∗ such that
P ∗(A) = E(φ · 1A) (6.6)
6.5 Equivalent martingale measure
Sometimes it is hard to find the statistical distribution of the underlying process you
are evaluating. Therefore it is possible to change the probability measure. The process
might fluctuate with for example a bond rate. Then by dividing by a numeraire P(0,T)
we obtain a new equivalent probability measure.
P˜ (A) =
1
P (0, T )
EP ∗(φ · 1A) (6.7)
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This transformation may ease computations of prices of interest rate derivates. In order
to maintain the risk neutral quality, the price process has to meet the risk neutral
requirements mentioned before, but now under the new transformed martingale measure.
When found, this measure is called an equivalent martingale measure. This measure
operates in a new risk neutral world.
6.6 LIBOR forward rate evolution
An example of a risk-free interest rate that can be used under the Solvency II directive,
is the LIBOR forward rate. I will therefore present its evolution in this section.
The problem with the interest rate estimations such as the Vasiceˇk model is that they
give explicit functions of the instantaneous spot interest rate. The LIBOR forward rate,
on the other hand, gives a continuous rate that models the evolution of the whole yield
curve forward in time. We will first look at the evolution of the LIBOR rate, then we
will illustrate how to simulate the LIBOR forward rate using theory introduced in this
chapter.
By applying a forward hedging strategy of the LIBOR rate, L(t,T), we have the following
expression
L(t, T ) =
P (t, T )P (t, T + δ)
δ · P (t, T + δ) , (6.8)
where P(t,T) denotes bonds with maturity T, and δ is the tenor of the LIBOR, i.e. 0.25
or 0.5 years. We want to find an expression for the evolution of the LIBOR forward
rate under an appropriate change of measure to ease computations. First we need the
Girsanov theorem.
6.6.1 Girsanov’s theorem
This theorem roughly says that an adapted process Ut, given by a Brownian motion
distorted by a noise remains Brownian under a new risk neutral probability measure P ∗.
A process is called adapted when it is dependent on a Brownian motion, Bs for s ≤ t.
We let Ut be











|Vs|2ds), 0 ≤ t ≤ T (6.10)
and assume that E[Zt] = 1 for all t. Then Zt is a martingale under P. The risk neutral
probability measure is defined
P ∗(A) = E[1A · ZT ] (6.11)
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and by Girsanov’s theorem, the process Ut is a new Brownian motion defined as in (6.9),
now under P ∗. It is therefore also a martingale under P ∗.
6.6.2 T-forward measure
A T-forward measure is a pricing measure absolutely continuous with respect to a risk-
neutral measure but rather than using the money market as numeraire, it uses a bond
P(0,T) with maturity T. We define the T-forward measure
P˜ T (A) =
1
P (0, T )
EP ∗ [1A ·D(t)] (6.12)





B˜Tt := B˜t −
∫ t
0
σ∗(s, T )ds (6.14)
is a Brownian motion under P˜ T by Girsanov’s theorem, and σ(t, T ) is the risk premium,
where σ∗(s, T ) =
∫ T
t σ(t, s)ds. The latter can be shown with the help of integration by
parts, Itoˆ’s formula and Girsanov’s theorem.
6.6.3 Evolution of L(t,T)










for a volatility parameter process
γ(t, T ) =
1 + δ · L(t, T )
δ · L(t, T ) · (σ
∗(t, T + δ)− σ∗(t, T )) (6.16)
Then the evolution of the LIBOR forward rate is given by
dL(t, T ) = γ(t, T )L(t, T )dB˜T+δt , 0 ≤ t ≤ T (6.17)
where B˜T+δt is a Brownian motion under P˜
T+δ. Details are supplemented in Appendix
A.1.
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6.7 LIBOR forward rate simulations
We will estimate the γ with a non random function γ˜ which will be derived from caplet
volatilities of market data. The forward rate simulation formula will derive from
dL(t, Tj) = γ˜(t, Tj)L(t, Tj)dB˜
Tj+1
t (6.18)
where the relationship B˜T2t , . . . , B˜
Tn+1
t must be found. The calculations are tedious
but straight forward and are supplemented in Appendix A.2. We end up with the
evolution















for 0 ≤ t ≤ Tj , j = 1, . . . , n. Simulations over three different time periods are plottet
in Appendix B.
6.8 Conclusion
We have looked at how to discount our best estimate cash flow using an arbitrage free
valuation. There are different alternatives to the risk-free interest rate, and we have
discussed the use of government bonds, LIBOR and EURIBOR rates, and swap rates.
All which lead to a theoretical risk free valuation. The negative side was that they only
gave the spot interest rate, and not the whole yield curve. That is why we looked at the
LIBOR forward rate, and illustrated how to simulate these forward rates. The theory
and the calculations involved were also presented.
There is more work to be done in order to determine the risk-free interest rate structure
which shall be used under the Solvency II directive. In the next chapter, where we are
going to derive the value of our insurance portfolio, we will not discount as described
in this chapter. We will instead link our cash flow to financial instruments. This will
enable us to achieve a market consistent valuation of the technical provisions throughout
the period, without the use of stochastic discount factors.




Now we will look at a new method of valuing an insurance company’s cash flow in-
troduced by Bu¨hlmann et al. [17]. It is a method of valuation which does not involve
discounting in the same manner as in chapter 6. It provides the possibility of finding
the market value of the technical provisions directly, and not only of the discounted best
estimate cash flow.
I have earlier stated that the technical provisions are made up of the discounted best
estimate cash flow, and a risk margin. The Solvency II directive stated that we are
allowed to valuate the two elements together when the future cash flow associated with
insurance obligations can be replicated using financial instruments for which market
values can be found. If so the value of the technical provisions should be determined
by the market value of those instruments that comprise the technical provisions. We
are therefore going to valuate the technical provisions as a unit, linked to financial
instruments and in that way determine the market value of the insurance portfolio.
When this valuation is found we will know how to obtain solvency, either by replicating
the portfolio we have found, by hedging, or by setting up a risk bearing capital.
In order to find the market value of the insurance portfolio we need to connect our
technical provisions to financial instruments. We will then obtain a market consistent
valuation of an insurer’s cash flow. The model is risk-adjusted and builds a bridge
between the actuaries and the asset managers by looking at the “total balance sheet”
instead of looking at the assets and liabilities separate. As of now the actuaries are
in charge of the liabilities, and the asset managers are in charge of the active side of
the balance sheet. This will most likely change when the new Solvency II directive is
implemented. The new directive concentrates both on the asset-side risk as well as the
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technical risk. Therefore there should be interaction between the asset and liability side.
By applying this new model we are able to measure both sides in one consistent way.
This should lead to a successful Asset Liability Management (ALM) strategy.
7.1 Market values for the cash flows
Our goal is to find a market consistent model for calculating the technical provisions cash
flow. We need to introduce a fair value concept. The definition of fair value is
the amount which an asset could be exchanged or a liability settled between
knowledgeable willing parties in an arm’s length transaction
The assets of a company can usually be traded in a market. The fair value for the
assets is, therefore, generally taken as equal to the market value. Our problem lies in
the fact that the technical provisions cash flow is not usually traded in a market. For
calculation we therefore might think of this value from a run-off situation, where the
insurance portfolio does not take in new members, but continues its business until the
last expenses are paid. In value this is equal to the amount one insurance company would
have to pay to another insurance company to transfer its obligations. The Solvency II
directive states
The value of technical provisions should therefore correspond to the amount
an insurance or reinsurance undertaking would have to pay if it transferred
its contractual rights and obligations immediately to another undertaking
So how should we valuate an insurance portfolio in life insurance? We begin by breaking
the procedure down into two separate steps. First we shall assume that the technical
provisions cash flow is deterministic. This means we assume the life table and mor-
tality rates are known. The only stochastic contribution will come from the financial
instruments we link our estimate to. In the next step we shall assume that we have a
stochastic technical provisions cash flow. We will then use the construction from the
first step, and add loadings for the technical risks that arise from a stochastic life table.
This will in the end give us the construction of a insurance portfolio, protected against
technical risk, and in terms of financial instruments. If we are able to find the market
value of the financial instruments then we have managed to find a market value for our
technical provisions.
We will follow an example of an insurance cash flow, where premium is paid in advance.
If the policyholder dies, a benefit is paid to the beneficiary. If the policyholder survives
until a predetermined age, he will receive the benefits he has accumulated.
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7.2 Deterministic life table
We assume that we have a deterministic life table, where no technical risk is involved.
The construction of such a valuation portfolio can be broken down into three steps. First
let lx denote the number of individuals alive in year x, and let dx denote the number of
individuals who are alive in year x, but die before reaching the year (x + 1). Then we
have the following general diagram:
year survived died
x lx
→ dx = lx − lx+1
x+1 lx+1
→ dx+1 = lx+1 − lx+2
x+2 lx+2




Further we will, as an example, denote the time by {t0, . . . , t5}.
7.2.1 Step 1
The first step is to determine into which units we are going to decompose the insurer’s
technical provisions. We will use the units of a multidimensional vector for the valuation.
Specifically, we divide the technical provisons cash flow into premium, death benefit,
and survival benefit. For our example we have a time line of five years, and it is divided
into
• an annual premium fixed in non-indexed Swiss francs (CHF). We let the premium
be constant for all years such that the premium Πt = Π. As units for the premium
we will use the zero-coupon bonds Z(t).
• survival benefit measured in an indexed fund I with price process (It)t. This means
that in this example the beneficiary does not receive a minimal guarantee in case
of survival.
• death benefit defined as the indexed maximum of Iti and (1+i)ti−t0 , for i ∈ (1, . . . , 5)
for a fixed minimum interest rate guarantee, i. We recognize this as a put op-
tion with strike (1 + i)ti−t0 at strike time ti with value max(I, (1 + i)ti−t0) for
i ∈ (1, . . . , 5). We denote the price of the put options Putti(I, (1 + i)ti−t0).
We define our valuation vector with the following units
(U1, . . . ,U11) = (Zt1 , . . . , Zt4 , I,Put(I, (1 + i)t1−t0), . . . ,Put(I, (1 + i)t5−t0)) (7.1)
54 7. MARKET CONSISTENT VALUATION OF TECHNICAL PROVISIONS
We will use this vector of units, and link them to financial instruments. This will enable
us to calculate the market value of our valuation portfolio.
We end up with this valuation scheme:
time premium death benefit survival benefit
t0 −lt0 ·Π · Z(t0)
t1 −lt1 ·Π · Z(t1) dt0 ·
(
I+ Put(I, (1 + i)t1−t0)
)
t2 −lt2 ·Π · Z(t2) dt1 ·
(
I+ Put(I, (1 + i)t2−t0)
)
t3 −lt3 ·Π · Z(t3) dt2 ·
(
I+ Put(I, (1 + i)t3−t0)
)
t4 −lt4 ·Π · Z(t4) dt3 ·
(




I+ Put(I, (1 + i)t5−t0)
)
lt5 · I
Table 7.1: Valuation scheme
7.2.2 Step 2
Now that we have found the units of our valuation portfolio we must find the number
of each unit needed. From the table 7.1 above it is easy to find this number.
• We see that for the units Z(t0), . . . , Z(t4), we need respectively −lt0 ·Π, . . . ,−lt4 ·Π
number of units.
• For the unit I we need lt0 number of units since lt0 = dt0 +dt1 +dt2 +dt3 +dt4 + lt5
using the definition for lx and dx.
• For the put option price units Put(I, (1 + i)t1−t0), . . . ,Put(I, (1 + i)t5−t0) we need
dt0 , . . . , dt4 number of units respectively.
Our cash flow is now mapped to the valuation portfolio, VaPo(X) which in turn maps
the cash flow onto an insurance portfolio consisting of financial instruments. Here X is
the cash flow of the insurance portfolio.
7.2.3 Step 3
We want a monetary value for the cash flow. This can be found by applying an accounting
principal ε to the valuation portfolio, VaPo(X), to find the market value. As before the
financial instruments will have to be valued based on its market price in the financial
market. We obtain
Vapo(X) 7→ ε(VaPo(X)) ∈ R (7.2)
Now that the financial instruments are divided into units the understanding between
actuaries and asset managers are eased. First the actuaries decompose the insurance
portfolio into units. They now know how much is needed of each unit. Then the asset
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managers, or the same actuary, can evaluate these units using an accounting principle.
For a cash flow X, like the best estimate element we now have
Q(X) = ε(VaPo(X)) =
∑
i
λi(X) · ε(Ui) (7.3)
where λi represents the number of units Ui.
7.2.4 Accounting principle
The accounting principle we use to comply with the solvency directive and regulatory
requirements is the market value, ε. The units are zero coupon bonds, indexes, deriva-
tives etc. The market value is in other words the price the asset can be exchanged for
in a financial market. Depending on the time we want to value our portfolio we will use
a time-dependent market value εs.
7.3 Stochastic life table
We call the best estimate of the liabilities in section 7.2 a deterministic model. In real
life the life table is stochastic, and so are the liabilities. To add the stochastic risk to it,
we therefore add a protection to the deterministic model. Examples of protection can
be reinsurance products, risk loadings, or an extra capital buffer specially for technical
risk.
So how much do we need in protection? We will need an expression that will involve the
unknown mortality values. We let Lx denote a random number of individuals alive in
year x, and Dx denote the random number of individuals who are alive in year x, and
die before year (x+1). We then end up with a slightly different diagram than before.
We use the same definition of the time, t = [t0, . . . , t5]. Now we have a whole lot of
unknowns. If we use dt0 as predictor for Dt0 and use the fact that dt0 = lt0 − lt1 we
obtain the prediction uncertainty for the mortality Dt0 − dt0 = lt1 − Lt1 .
If we define px =
lx+1
lx
and qx = 1− px we get the expression for the additional reserves
we need. For t1 we need an additional
(Dt0 − dt0) ·
(




in reserves where X(t2) refers to the cash flow (0, 0, X(t2), X(t3), X(t4), X(t5)). If our
stochastic mortality rate is higher than our deterministic rate several things occur. We
need to pay more in death benefits at the specific time period. But due to the higher
mortality we will have fewer contracts in our portfolio. Even though we receive less
premium caused by the terminated contracts, higher mortality reduces our liabilities.
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We therefore need to calculate with a new VaPo from time t2. For t2, . . . , t5 we need
respectively
(Dt1 − qt1 · Lt1) ·
(




(Dt2 − qt2 · Lt2) ·
(




(Dt3 − qt3 · Lt3) ·
(




(Dt4 − qt4 · Lt4) · (I+ Put(I, (1 + i)t5−t0)− I (7.8)
in additional reserves. The added protection mentioned earlier can be given by a rein-
surance premium loading like
RPPt0 = lt0 · (q∗t0 − qt0) ·
(




RPPt1 = lt1 · (q∗t1 − qt1) ·
(




RPPt2 = lt2 · (q∗t2 − qt2) ·
(




RPPl3 = lt3 · (q∗t3 − qt3) ·
(




RPPt4 = lt4 · (q∗t4 − qt4) ·
(
I+ Put(I, (1 + i)t5−t0)− I) (7.13)
where q∗x − qx denotes the rate charged by the reinsurer subtracted the technical risk
which combined equals the loading. Our valuation portfolio for stochastic mortality rate
VaPoProt can now be described as





As before the cash flow is decomposed into a vector whose basis consists of financial
instruments. To find the monetary value of the reinsurance premium we can again apply
the market value accounting principle, ε, to our new protected portfolio, the VaPoProt.
The reinsurance premium valuated at time s is given by the equation (7.15) for a general
x,
ΠRex = εs(RPPx)
= lx · (q∗x − qx)
· εs
(





The market value of the valuation portfolio protected against technical risk at time t
can be expressed by




By applying this accounting principal to our valuation portfolio onto the financial in-
struments, earlier defined as Ut, it is possible to calculate a monetary value with the
“total balance sheet” approach.
7.4 Conclusion
We have introduced a method of valuing our insurance portfolio with the help of financial
instruments. There are however several simplifications in our method. The time period
for the portfolio is predetermined. The modeling of options and guarantees might in
fact become very difficult, e.g. incomplete markets. The choice of financial instruments
to which we link the insurer’s cash flow is arbitrary and we might as well choose other
financial instruments.
However, the method illustrates how to divide the valuation portfolio into units of finan-
cial instruments. It creates a way for us to find the market value of our liabilities, which
was our goal. This happens when we apply an accounting principal, and we obtain the
monetary value of the valuation portfolio. To calculate the valuation portfolio protected
against technical risk, we added the valuation portfolio and an additional reserve with
a loading charged from the reinsurer. We have not specified how to find this loading,
and it is yet another simplification in our method. In the next chapter we will look at a
numerical example of the theory described. We will see how to use the steps given in this
chapter, and determine the way the financial instruments and units are chosen.
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8NUMERICAL EXAMPLE OF A
VALUATION PORTFOLIO
We are now ready to look at a numerical example of how to compute the valuation
portfolio using realistic values. We follow the steps from chapter 7. We start out by
assuming that we are dealing with a deterministic life table. Afterwards we will add a
protection to our valuation portfolio to protect against technical risk in order to obtain
the VaPoProt.
For our example we will consider a policy starting in the year 2000 and lasting until
2005. We will use the deterministic life table from table 8.1 of 1,000 policyholders in the
starting year. We shall further assume a guaranteed interest rate of i = 3.00%, which
was the guaranteed interest rate in 2000. The benefits follow an indexed fund I with
I2000 = 1.
Time Year Survived Dead
lyear dyear
t0 2000 lt0 = 1000
t1 2001 lt1 = 996 dt1 = 4
t2 2002 lt2 = 991 dt2 = 5
t3 2003 lt3 = 986 dt3 = 5
t4 2004 lt4 = 981 dt4 = 5
t5 2005 lt5 = 975 dt5 = 6
Table 8.1: Example of a deterministic life table
Let us define a time index s which satisfies t0 ≤ s < t5. We choose an equity-linked
insurance contract with Is denoting the price process of the equity index I valued at
time s. We use the market value as our accounting principal, and let εs(I) define the
market value of I at time s.
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We denote the price process of a zero coupon bond as Z(t) with maturity in year t. We
find its market value in year s by the following calculation
Z(t)s = Q(Z
(t)|Fs) = εs(Z(t)) for s < t (8.1)




The equity index and the yield curves R(s,t) are given in table 8.2 for years 2000-
2005.
R(s,t)
Year, s Is t-s = 1 t-s = 2 t-s = 3 t-s = 4 t-s = 5
2000 1 3.37% 3.52% 3.53% 3.56% 3.60%
2001 1.090 2.00% 2.85% 2.90% 2.96% 3.02%
2002 0.963 0.69% 1.84% 2.14% 2.38% 2.57%
2003 0.830 0.58% 0.79% 1.14% 1.46% 1.94%
2004 0.973 0.99% 1.11% 1.42% 1.70% 1.94%
2005 0.991 1.41% 1.14% 1.32% 1.48% 1.62%
Table 8.2: The equity index Is, and yield curve R(s,t)
In order to find the an expression for the put option price we need to determine the
dynamics of our equity index. We need to find the dynamics of our equity index, in
order to find an expression for the put option price. The equity index is stochastic, with






, for s < t and fixed t (8.3)
By transforming the price process with a change of numeraire we are able to use our
expression with a non-constant interest rate.
We shall assume I˜s is a martingale under the risk neutral measure and satisfies
dI˜s = σI˜sdBs, (8.4)
where Bs is a Brownian motion under the risk neutral measure.
We want to find a general expression for the dynamics of I˜t, which is the price process
of the equity index at time t, valued at time s. In order to compute the dynamics of I˜t
we will use Itoˆ’s lemma. We start out with the two equations





= σ2I˜2t dt, since dB
2
t := dt (8.6)
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and use Itoˆ’s lemma on the expression (ln I˜t)






















= σdBt − 12σ
2dt, (8.8)
where we in equation (8.7) have inserted the equations (8.5) and (8.6). To determine the

























With the dynamics of I˜t, we are ready to find an expression for the put option price. We







Since σBt−s has the distribution N (0, σ2(t − s)), σBt−s can also be expressed by the
equivalent distribution σ
√
t− s · , because of the definition of . The put option price
formula is then given by






























where we valuate the expression at time s.
By solving the integration limit {(1 + i)t−t0 > I˜se− 12σ2(t−s)+σ
√
t−s·y} with respect to y,











t− s > y (8.12)
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(1 + i)t−t0q(y)dy = Z(t)s (1 + i)
t−t0 · Φ(a), (8.13)
where Φ(·) is the cumulative distribution function for a standard normal distribution such
























2 dv, where v = y − σ√t− s
= Z(t)s · I˜s · Φ(−σ
√
t− s+ a) (8.14)
Using equation (8.3) we get the following expression for the put option price
























We will use a guaranteed interest rate of i = 3%. Index I is described in table 8.2 and
σ = 0.15 was used. Hence we have the following put option prices valued from years
2000 through 2004, calculated for the remaining years of the policy for all years.
s
t
2001 2002 2003 2004 2005
2000 0.053 0.069 0.080 0.088 0.093
2001 0.034 0.051 0.066 0.076
2002 0.117 0.131 0.144
2003 0.249 0.267
2004 0.140
Table 8.3: Put option prices valued at time s, with strike time t
Now we can calculate the premium Π for the valuation portfolio X. The premium and
the expenses paid must be equal seen from time t0 by the premium equivalence principle.
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Hence
εt0(VaPo(X)) = εt0(−(lt0Zt1 + lt1Zt2 + lt2Zt3 + lt3Zt4 + lt4Zt4) ·Π
+ dt1(I+ Put(I, (1 + i))) + dt2(I+ Put(I, (1 + i)
2))
+ dt3(I+ Put(I, (1 + i)
3)) + dt4(I+ Put(I, (1 + i)
4))+
+ dt5(I+ Put(I, (1 + i)
5)) + lt5 · I) (8.16)
= 0 (8.17)
We solve for Π given that
• both the survival and death capital at time t0 was 100,000 of an arbitrary currency.
• the market value of the index I is given by εt0(I) = It0 .
• the market value of the zero coupon bond Zt is given by εt0(Zt) = Ztt0
• the market value of the put option is given by εt0(Put(I, (1+i))) = Putt0(It0 , (1+i)).
We obtain a premium of Π = 21, 675. Now we have all the results we need to be able to
calculate the valuation portfolio cash flow valuated for each year. For year s the value
of the valuation portfolio is given by
εs(VaPo(X(s+1))−Π · ls · Z(s))) (8.18)
where X(s+1) is all of the remaining cash flows from time s+1. Mathematically, X(s+1) =
(0, . . . , Xs+1, . . . Xt). If we let the time run between s = (2000, . . . , 2004) then the value







Table 8.4: Market value of valuation portfolio cash flow at time s
Taking into account to a stochastic mortality, we want to find the reinsurance premium
charged by a reinsurer. We use equation (7.15), and the market value at time t0, εt0 .
For our example, we use the stress parameter from the Solvency II directive, an increase
in the mortality rate of 10% for each year. This gives us q∗t = 1.1 · qt.







Table 8.5: Reinsurance premium
Our insurance portfolio only lasts for five year. We see that the closer we get to the
end, the reinsurance premium charge decreases. The reason is that all of the risk factors
decreases.
8.1 Conclusion
By following the steps and dividing the valuation portfolio into units of financial in-
struments, valuation becomes a pretty straight forward computation. The computation
of the reinsurance premium can also be found without significant struggle. There are
however simplifications in the calculation.
• The life table and mortality table will not be given by a discrete table, but rather as
a survival probability formula depending on age for each individual. See discussions
in chapter 5.
• We have assumed that the fixed minimal guarantee rate i is a constant figure. This
might be true for shorter time periods such as 5-10 years, but will probably change
over a longer period depending on the financial market. If the market is in trouble,
the guarantee can be impossible to achieve. And an insurance company will have
to pay higher and higher put option prices.
• In order to compensate for losses, both financial and technical, the insurance com-
pany can adjust the premium. I have assumed that the premium stays constant
throughout the policy lifetime.
• Maybe the most crucial of the simplifications is that we have assumed that we can
find all the financial instruments we need in the financial market. This is probably
a too optimistic assumption.
• The reinsurance loading is defined as a constant factor times the mortality probabil-
ity. In reality these loadings may be negotiated and changed each year depending
on last years results. It is however realistic that the loading should be a more
complex function of the mortality probability.
9ASSET LIABILITY
MANAGEMENT
In the previous chapter we have found expressions for two different valuation portfolios.
The VaPo with deterministic mortality, and the VaPoProt which is the portfolio with
stochastic mortality protected against technical risks with an extra reinsurance loading.
I will consider the latter in this chapter. This chapter deals with the asset and liability
management of insurance portfolios based on the construction of “solvency strategies”
as proposed by Bu¨hlmann et al. [17]. We will assume that the financial instruments we
need for the construction of the VaPoProt can be bought in the assets market. We will
compare the VaPoProt to a real asset portfolio S of the insurance undertaking. S has to
be greater or equal to the valuation portfolio to obtain solvency.
9.1 Market risk
Market risk is another expression for financial risk which is the risk of the actual invest-
ment return being less than the expected return. If we were to buy the exact units of
financial instruments of which the VaPoProt consists, we would have avoided all market
risk. And since the VaPoProt is protected against technical risk, there would be no risk.
There are however reasons for not applying this strategy. For one, companies are in-
terested in maximizing their financial return. Taking additional market risk opens the
possibility for higher returns.
9.1.1 Solvency definition
Before I describe how the asset portfolio should look like we need to define solvency
according to the Solvency II directive. We use the economic accounting principal εs.
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As before εs corresponds to the market price at time s paid at the asset market for the
financial instruments. At time t0 a company is solvent if
εt0(S) ≥ εt0(VaPoProt) (9.1)
But a company should be solvent through all the time periods ahead, so from an overall
perspective of an insurance portfolio the following must hold
εs(S) ≥ εs(VaPoProt) ∀ s > t0 (9.2)
The Solvency II directive divide the time period into time intervals of one year when
considering solvency. So for the accounting condition we make sure we are solvent for
the time period [t0, t0+1]. Then at time (t0+1) we iterate the procedure and find a new
accounting condition. Therefore the Solvency II definition is decoupled into an iterative
process. This iteration may cause problems in practice when trying to find market values
for assets which have maturity many years ahead. It is however the definition we will
use to comply with the solvency directive.
9.1.2 ALM mismatch
The big question is how to choose the asset portfolio S. One suggestion is to define S
such that
S = VaPoProt + F (9.3)
where VaPoProt is self-financing, and F is excess capital which has to be positive. From
a mathematical point of view this would ensure solvency, and shows that solvency is
possible. In real life however there are a few problems with this portfolio construction.
One problem is that the financial instruments might not be available for purchase at
all times even though they exist i.e. the put option. Another problem arises when
we have very long term liabilities. It is often impossible to find financial instruments
with such long time perspectives as 30 years ahead, especially in smaller countries and
financial communities such as Norway. The fact remains that S should not actually
contain VaPoProt. To maximize returns a company will take higher market risk causing
a mismatch between the asset portfolio and their liabilities. This mismatch is called
ALM mismatch.
If we cannot find the long term assets we need in order to replicate our liabilities we
use a strategy that leads to mismatch. We build ourselves a replicating portfolio which
consists of assets with shorter maturities than our liabilities, and rebalance the portfolio
at maturity. A replicated portfolio means a portfolio that is possible to construct using
instruments from the financial market.
Mismatch between the asset portfolio and the company’s liabilities will cause higher
market risk, and the company is, by the Solvency II directive, required to hold additional
capital for protection against market risk. In life insurance protection against market
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risk turns out to be by far the most dominant requirement for capital, even compared
to the capital required for protection against technical risk, see section 4.1.1, second
paragraph.
9.2 Marbrage option
We want to use a financial instrument to ensure solvency. The goal is to be able to protect
us against unfavorable events, while maximizing returns. We will again assume that the
financial instruments included in the VaPoProt are available in the assets market. Then
there exists a strategy that leads to a valuation portfolio that protects the undertaking
against market risk. This strategy is to define the asset portfolio S as
S = S˜ + M + F (9.4)
where S˜ is any asset portfolio which satisfies the solvency requirement, equation (9.2).
M is the price needed to buy a Marbrage option, and F is excess capital which is required
to be strictly positive at all times. A Margrabe option is a financial instrument that
gives the buyer the right to exchange one asset for another. In our case we want the
possibility of switching from S˜ to VaPoProt at the end of every accounting year. In order
to do this we buy a Margrabe option with price M. In our case it gives us the right to
switch from the asset portfolio S˜ to the VaPoProt whenever
εt0+1(VaPo
Prot) > εt0+1(S˜) (9.5)
The valuation portfolio protects both against technical risk and market risk and is with
the use of a Margrabe option equal to S˜ +M . For valuation at time t this implies
Prot = εt(S˜) +Mt (9.6)
The Margrabe option enables us to take risks with our asset portfolio, S˜, by ALM
mismatch. If our risky strategy fails we can switch assets. We are therefore able to cover
our liabilities regardless of the outcome, hence solvency is guaranteed.
We now decouple the solvency problem into recursive one-period problems, where we
each year spend the price of a Margrabe option in order to be covered. This covers the
mismatch between the VaPoProt and S˜.
The Margrabe option price is derived by Gerber and Shiu [8] and is given by the formula
(9.9) where
x1 = εt[V aPoProt] (9.7)
x2 = εt[S˜] (9.8)
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the valuation occurs at time s for a price at time t, and








d2 = d1 − v
√
t− s (9.11)
Φ is as before the cumulative standard normal density function, and v2 = σ21−2σ1vσ2ρ+
σ22 is the variance of (x1/x2)
−1d(x1/x2).
To derive the Margrabe option price Gerber and Shiu have switched to an equivalent
martingale measure in order to achieve a martingale option price, see details in Appendix
C. The transformation they have used is called an Esscher transform. This transforma-
tion is a well-known method used in actuarial mathematics, and is a useful technique
to obtain a reasonable fair value equivalent martingale measure. The Esscher trans-
form allows us to find a deflator which achieves the martingale property. In a complete
arbitrage-free market there exists only one unique equivalent martingale measure. If we
on the other hand operate in an incomplete financial market, the equivalent martingale
measure is no longer unique. In this case there exist several equivalent martingale mea-
sures such as a minimal entropy martingale measure or Esscher martingale measure. The
minimal entropy martingale measure is preferred because of the large deviation theory.
According to Miyahara [12] and Sanov’s theorem
the minimal entropy martingale measure is the most possible empirical prob-
ability measure of paths of price process in the class of the equivalent mar-
tingale measures.
The theory of the minimal entropy measure is beyond the scope of this thesis. The
Esscher transform is often not applicable to heavy-tailed distributions. Therefore this
calculation is not suitable for the non-life insurance industry, but in life insurance its use
can be justified.
9.3 Hedging Margrabe option
It may often not be possible to actually buy the Margrabe option for all time periods.
The option might not even exist in an incomplete market. Therefore we can construct a
strategy where we end up with the value of the Prot from equation (9.6). This strategy
is called hedging. Let us define a function H
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where x1 and x2 are defined in (9.7) and (9.8), and Mt is defined in (9.9). To find a













Since x follows a Brownian motion (dx)2 = dt. We want the expression to be a martingale
under P. For that to be the case, the dt terms must equal zero. We therefore want to


























































in x1 = εt[V aPoProt] and










in x2 = εt[S˜]. We recognize a = Φ(d1), and b = 1− Φ(d2). We get
a · x1 + b · x2 = x2 +Mt = εt(S˜) +Mt
= Prot (9.19)
From equation (9.6). We have found a hedging strategy which leaves us with the exact
same amount as if were to buy the Margrabe option. Hence solvency is ensured.
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9.4 Risk bearing capital
Another possibility instead of buying the Margrabe option is to finance a risk bearing
capital. We can e.g. use expected shortfall or the value at risk as our risk measure. For









≥ 1− , (9.20)
where P ∗ is the equivalent martingale measure. The risk bearing capital approach is
not optimal because we do not have the possibility of switching assets if the results one
year is catastrophic. The probability of having too little capital is, on the other hand,
very small depending on which  we choose. A natural choice could be  = 0.01. This
method of covering risk is a practical approach, and is applied under the Swiss Solvency









≤ −log(1 + qt0)|Ft0
]
= 1−  (9.21)
then by subtracting with the expected investment rate and dividing by the standard
deviation we get a normalization
Φ




and we finally achieve the expression
qt0 = 1− exp(−σ · Φ−1() + µ) (9.23)
We have found an expression with two unknowns, both the expectation of the investment
return, and the standard deviation. We can set the expectation equal the risk free rate.
The standard deviation should be a function of the expectation since higher return
increase the volatility.
9.5 Conclusion
Our main goal is to remain solvent. But we also want to maximize our investment
returns. We have looked at three methods of achieving this, either by buying a Mar-
grabe option, by hedging a Margrabe option or by setting aside enough risk bearing
capital.
The first two choices take use of the financial market, and is therefore automatically
market consistent. The problem with buying the Margrabe option is that it might not
exist in the financial market. Therefore we looked at the option of hedging the option.
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These two methods solve our solvency problem by each year spending the price of the
Margrabe option to protect against financial risk. The price found measures the ALM
mismatch between the real asset portfolio, and the liability portfolio. The last choice
takes use of a risk measure and uses a quantile hedging approach. This method is not
favorable because it is not market consistent, and is not dependent on the financial
market.
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Appendix A
LIBOR forward rate
A.1 Evolution of the LIBOR forward rate
The method is proposed by Proske [15]. The equation (6.17) can be written as
L(t, T ) = L(0, T ) +
∫ t
0
γ(s, T ) · L(s, T )dB˜T+δs (A.1)
This is the expression we want to find. We apply Itoˆ’s formula on (A.2), as described in
section 6.6.3. We set










Then we see that




(dX)2 = γ2(s, Tj)ds (A.5)
Itoˆ’s formula on Yt has the solution

























Ys = L(s, T ) = L(0, Tj)eXt (A.8)
We have now derived the expression (A.1) we wanted to show.
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A.2 Simulation formula
We take in use equation (6.14) and state that
dB˜
Tj




t := dB˜t + σ
∗(t, Tj+1)dt (A.10)
We subtract the equations
dB˜Tj = (σ
∗(t, Tj)− σ∗(t, Tj+1))dt+ B˜Tj+1t (A.11)
























1 + δL(t, Ti)
dt+ dB˜tTn−1 (A.16)
for j+ 1 ≤ n. We use γ˜(t, Tj) ≈ γ(t, Tj) and A.8 and insert B˜Tj+1s into Xt from equation
(A.3) and end up with















which is the simulation formula for the LIBOR forward rate.
Appendix B
LIBOR forward rate plots
The tenor used is δ = 14 . The three time periods considered are T1, T2 and T3. The simu-
lations are divided into three combined steps. The volatility parameters given are
γ˜(t, T1) = 16.05%, γ˜(t, T2) = 16.12%, γ˜(t, T3) = 16.19% (B.1)
The data is collected from Bloomberg in June 2009. The underlying Brownian motion
used was B˜T4t . The superscript T4 demonstrates that the same Brownian motion is used
for all of the three time periods. The Brownian motion is actually simulated one whole
year ahead. B˜T4t was found by simulating
Bi = Bi−1 +  ·
√
1/N (B.2)
where B0 = 0, N where the amount of points chosen, and  ∼N(0,1). The LIBOR is
measured in US dollars. The LIBOR interest rates where L(0, T3) = 1.85%, L(0, T2) =
1.74% og L(0, T1) = 1.50% respectively. I have simulated 20 possible paths for the
forward LIBOR rate in each of the three steps.
The exercise shows the possibility of simulating LIBOR forward rates.
B.1 Step 1
The first step corresponds to the period 0 ≤ t ≤ T3 which is the time period up to 9
months.
L(t, T3) = L(0, T3) · exp
{
16.19% · B˜T4t −
1
2
· t · (16.19%)2
}
(B.3)
I have used 750 points to simulate a brownian motion.
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Figure B.1: 9 months LIBOR rate
B.2 Step 2
The second step corresponds to the period 0 ≤ t ≤ T2 which is the time period up to 6
months. The simulation formula is
L(t, T2) = L(0, T2)exp
{




16.12% · −(δ · 16.9% · L(s, T3)





· t · (16.12%)2
}
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Figure B.2: 6 months LIBOR rate
B.3 Step 3
The last step corresponds to the period 0 ≤ t ≤ T1 which is the time period up to 3
months. The formula is given by







16.05% · (−δ · 16.12% · L(s, T2)
1 + δL(s, T2)
− δ · 16.19% · L(s, T3)






· t · (16.05%)2
}
The variation between the simulations become smaller with shorter time periods, as
should be expected.
B.4 Against each other
Finally I plotted one simulation for each of the three time periods together in a single
plot. They follow each other closely due to the same underlying brownian motion, even
though they have different starting values, and expressions.
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Figure B.3: 3 months LIBOR rate
























Figure B.4: The three time period in the same plot
Appendix C
Esscher transform
The Esscher transform is an actuarial technique, and is a powerful valuation tool (in
incomplete markets). We will see how it helps us find an equivalent martingale measure
to a discounted price process.
Let us consider a general stochastic process x(t), t > 0, with stationary and independent
increments, and initial value x(0) = 0. Its price is growing with an interest rate which
follows a stochastic process denoted by Y(t).
x(t) = x(0) · eY (t) (C.1)
We assume that the random variable Y(t) has a probability density function f(y,t). The
moment generating function M(z,t) of Y(t) is defined by















M(z + h, t)
M(h, t)
(C.5)
Since M(z,t) is continous in t, it can be shown that
M(z, t;h) = [M(z, t;h)]t (C.6)
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In order to find the risk neutral Esscher transform we want to find a h = h∗ such that the
discounted price process eδtx(t) is a martingale with respect to the probability measure
corresponding to h∗. The probability density function for E∗ is f(y, t;h∗). δ denotes the
risk-free force of interest. We want
x(0) = E∗[eδtx(t)] = eδtE∗[x(t)] (C.7)
Using equation (C.1), h∗ is the solution of
1 = eδtE∗[eY (t)] , or (C.8)
eδt = M(1, t;h∗) (C.9)
Setting t = 1, we obtain,
δ = ln[M(1, 1;h∗)] (C.10)
It can be shown that there is a unique solution h∗ ∈ RL which satisfies (C.9) for all
t =1, . . . , L. Hence we have found the discount factor δ which gives an equivalent mar-
tingale measure for the price process.
Appendix D
R-code
D.1 Code to the numerical example of a valuation portfo-
lio
1
2 #zero coupon bond y i e l d cu r v e s
3 R1 = c (0 . 0337 , 0 .0352 , 0 .0353 , 0 .0356 , 0 . 036)
4 R2 = c ( 0 . 0 2 , 0 .0285 , 0 .029 , 0 .0296)
5 R3 = c (0 . 0069 , 0 .0184 , 0 .0214)
6 R4 = c (0 . 0058 , 0 .0079)
7 R5 = c ( 0 . 0099 )
8
9 #c a l c u l a t e s t h e put op t i on p r i c e g i v en th e s t a r t t ime s , and y i e l d curve
10 put = function ( s ,R){
11 T = 2005
12 t0 = 2000
13 sigma = 0.15
14 i = 0.03
15 m = T−s
16 j = s−t0+1
17 I = c (1 , 1 .089806 , 0 .9626167 , 0 .8299416 , 0 .9726801)
18 z = rep (NA,m)
19 z [ 1 :m] = exp(−c ( 1 :m)∗R[ 1 :m] )
20 K = z∗(1+ i ) ˆc ( j : (T−t0 ) )
21 a1 = (−log ( I [ j ] /K) + 0.5∗(c ( 1 :m) )∗sigma ˆ2)/ ( sigma∗sqrt (c ( 1 :m) ) )
22 a2 = a1 − sigma∗sqrt (c ( 1 :m) )




27 I = c (1 , 1 .089806 , 0 .9626167 , 0 .8299416 , 0 .9726801 , 0 .990644)
28 d = c ( 4 , 5 , 5 , 5 , 6 )
29 l = c (1000 , 996 , 991 , 986 , 981 , 975)
30
31 #c a l c u l a t e s t h e premium
32 Pi = 100000∗(d [ 1 ] ∗(1+put (2000 ,R1) [ 1 ] ) + d [ 2 ] ∗(1+put (2000 ,R1) [ 2 ] ) +
33 d [ 3 ] ∗(1+put (2000 ,R1) [ 3 ] )
34 + d [ 4 ] ∗(1+put (2000 ,R1) [ 4 ] ) + d [ 5 ] ∗( I [1 ]+ put (2000 ,R1) [ 5 ] ) + l [ 6 ] ) /
35 ( l [1 ]+ l [ 2 ] ∗exp(−1∗R1 [ 1 ] ) + l [ 3 ] ∗exp(−2∗R1 [ 2 ] )
36 + l [ 4 ] ∗exp(−3∗R1 [ 3 ] ) + l [ 5 ] ∗exp(−4∗R1 [ 4 ] ) )
37
38
39 PiR = rep (0 , 5 )
40 Ep = rep (0 , 5 )
41 Em = rep (0 , 5 )
42
43 #c a l c u l a t e s t h e market v a l u e o f t h e v a l u a t i o n p o r t f o l i o
44 Em[ 1 ] = −Pi∗( l [ 2 ] ∗exp(−1∗R1 [ 1 ] ) + l [ 3 ] ∗exp(−2∗R1 [ 2 ] )
45 + l [ 4 ] ∗exp(−3∗R1 [ 3 ] ) + l [ 5 ] ∗exp(−4∗R1 [ 4 ] ) ) + 100000∗(d [ 1 ] ∗( I [1 ]+ put (2000 ,R1) [ 1 ] )
46 + d [ 2 ] ∗( I [1 ]+ put (2000 ,R1) [ 2 ] ) + d [ 3 ] ∗( I [1 ]+ put (2000 ,R1) [ 3 ] )
47 + d [ 4 ] ∗( I [1 ]+ put (2000 ,R1) [ 4 ] ) + d [ 5 ] ∗( I [1 ]+ put (2000 ,R1) [ 5 ] ) + l [ 6 ] ∗I [ 1 ] )
48
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49
50 Em[ 2 ] = −Pi∗( l [ 3 ] ∗exp(−1∗R2 [ 1 ] )
51 + l [ 4 ] ∗exp(−2∗R2 [ 2 ] ) + l [ 5 ] ∗exp(−3∗R2 [ 3 ] ) ) + 100000∗(
52 d [ 2 ] ∗( I [2 ]+ put (2001 ,R2) [ 1 ] ) + d [ 3 ] ∗( I [2 ]+ put (2001 ,R2) [ 2 ] )
53 + d [ 4 ] ∗( I [2 ]+ put (2001 ,R2) [ 3 ] ) + d [ 5 ] ∗( I [2 ]+ put (2001 ,R2) [ 4 ] ) + l [ 6 ] ∗I [ 2 ] )
54
55
56 Em[ 3 ] = −Pi∗( l [ 4 ] ∗exp(−1∗R3 [ 1 ] ) + l [ 5 ] ∗exp(−2∗R3 [ 2 ] ) ) + 100000∗(
57 d [ 3 ] ∗( I [3 ]+ put (2002 ,R3) [ 1 ] )
58 + d [ 4 ] ∗( I [3 ]+ put (2002 ,R3) [ 2 ] ) + d [ 5 ] ∗( I [3 ]+ put (2002 ,R3) [ 3 ] ) + l [ 6 ] ∗I [ 3 ] )
59
60
61 Em[ 4 ] = −Pi∗( l [ 5 ] ∗exp(−1∗R4 [ 1 ] ) ) + 100000∗(
62 d [ 4 ] ∗( I [4 ]+ put (2003 ,R4) [ 1 ] ) + d [ 5 ] ∗( I [4 ]+ put (2003 ,R4) [ 2 ] ) + l [ 6 ] ∗I [ 4 ] )
63
64
65 Em[ 5 ] = 100000∗(d [ 5 ] ∗( I [5 ]+ put (2004 ,R5) [ 1 ] ) + l [ 6 ] ∗I [ 5 ] )
66
67 Ep [ 2 : 5 ] = Em[ 2 : 5 ] − l [ 2 : 5 ] ∗Pi
68
69 #c a l c u l a t e s t h e r e i n su rance l o a d i n g a t t ime t0
70 r e a s s = function ( inc mort ){
71 PiR = rep (0 , 5 )
72 load ing = inc mort − 1
73 PiR [ 1 ] = ( load ing∗ l [ 2 ] ∗(1− l [ 2 ] / l [ 1 ] ) ) ∗ (100000∗( I [ 1 ] + put (2000 ,R1) [ 1 ] ) + ( Pi )∗exp(−R1 [ 1 ] ) −
74 (−Pi∗( l [ 3 ] ∗exp(−2∗R1 [ 2 ] )
75 + l [ 4 ] ∗exp(−3∗R1 [ 3 ] ) + l [ 5 ] ∗exp(−4∗R1 [ 4 ] ) ) + 100000∗(d [ 2 ] ∗( I [1 ]+ put (2000 ,R1) [ 2 ] ) +
76 d [ 3 ] ∗( I [1 ]+ put (2000 ,R1) [ 3 ] )
77 + d [ 4 ] ∗( I [1 ]+ put (2000 ,R1) [ 4 ] ) + d [ 5 ] ∗( I [1 ]+ put (2000 ,R1) [ 5 ] ) + l [ 6 ] ∗I [ 1 ] ) )/ l [ 2 ] )
78
79 PiR [ 2 ] = ( load ing∗ l [ 3 ] ∗(1− l [ 3 ] / l [ 2 ] ) ) ∗ (100000∗( I [ 1 ] + put (2000 ,R1) [ 2 ] ) + Pi∗exp(−2∗R1 [ 2 ] ) −
80 (−Pi∗( l [ 4 ] ∗exp(−3∗R1 [ 3 ] ) + l [ 5 ] ∗exp(−4∗R1 [ 4 ] ) ) +
81 100000∗(d [ 3 ] ∗( I [1 ]+ put (2000 ,R1) [ 3 ] )
82 + d [ 4 ] ∗( I [1 ]+ put (2000 ,R1) [ 4 ] ) + d [ 5 ] ∗( I [1 ]+ put (2000 ,R1) [ 5 ] ) + l [ 6 ] ∗I [ 1 ] ) )/ l [ 3 ] )
83
84 PiR [ 3 ] = ( load ing∗ l [ 4 ] ∗(1− l [ 4 ] / l [ 3 ] ) ) ∗ (100000∗( I [ 1 ] + put (2000 ,R1) [ 3 ] ) + Pi∗exp(−3∗R1 [ 3 ] ) −
85 (−Pi∗( l [ 5 ] ∗exp(−4∗R1 [ 4 ] ) ) +
86 100000∗(d [ 4 ] ∗( I [1 ]+ put (2000 ,R1) [ 4 ] ) + d [ 5 ] ∗( I [1 ]+ put (2000 ,R1) [ 5 ] ) + l [ 6 ] ∗I [ 1 ] ) )/ l [ 4 ] )
87
88 PiR [ 4 ] = ( load ing∗ l [ 5 ] ∗(1− l [ 5 ] / l [ 4 ] ) ) ∗ (100000∗( I [ 1 ] + put (2000 ,R1) [ 4 ] ) + Pi∗exp(−4∗R1 [ 4 ] ) −
89 (100000∗(d [ 5 ] ∗(1+put (2000 ,R1) [ 5 ] )+l [ 6 ] ) )/ l [ 4 ] )
90
91 PiR [ 5 ] = load ing∗ l [ 6 ] ∗(1− l [ 6 ] / l [ 5 ] ) ∗100000∗( put (2000 ,R1) [ 5 ] )
92 return (PiR)
93 }
D.2 Code to the simulation of the LIBOR forward rate
1 # Simu la t e s 20 d i f f e r e n t pa th s
2 m = 1000
3
4 #s imu l a t e s Brownian motion
5 b = function (m) {
6 B = rep (0 ,m)
7 B [ 1 ] = 0
8 for ( i in 2 :m){





14 #P l o t s t h e s imu l a t i o n s
15 go = function ( sim ){# sim = 20
16 L1 = matrix (NA, nrow = (0 .25∗m) , ncol = sim )
17 L2 = matrix (NA, nrow = (0 . 5∗m) , ncol = sim )
18 L3 = matrix (NA, nrow = (0 .75∗m) , ncol = sim )
19 for ( i in 1 : sim ){
20 B = b(m)
21 L3 [ , i ] = LIBOR3(B)
22 L2 [ , i ] = LIBOR2(B)
23 L1 [ , i ] = LIBOR1(B)
24 }
25 p l o t s (L1 , L2 , L3 , sim )
26 }
27
28 # P l o t f u n c t i o n
29 p l o t s = function (L1 , L2 , L3 , sim ){
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30 #stepOne (L3 , sim )
31 #stepTwo (L2 , sim )




36 #p l o t s one s imu l a t i o n s o f each s t e p up a g a i n s t each o t h e r .
37 sammen = function ( ) {
38 L1 = c (NA, ( 0 . 2 5∗m) )
39 L2 = c (NA, ( 0 . 5 ∗m) )
40 L3 = c (NA, ( 0 . 7 5∗m) )
41 B = b(m)
42 L3 = LIBOR3(B)
43 L2 = LIBOR2(B)
44 L1 = LIBOR1(B)
45 pdf ( ”sammen . pdf ” )
46 plot (main = ”The s t ep s p lo t t ed aga in s t each other ” , lwd = 3 , xlab = ”Time s t eps ” , ylab = ”
LIBOR” , L3 , type = ’ l ’ , ylim = c ( 0 . 0 1 , 0 . 0 3 ) )
47 l ines (L2 , lwd = 2)
48 l ines (L1 , lwd = 1)
49 legend ( 0 , 0 . 0 3 , legend = c ( ”Step 1” , ”Step 2” , ”Step 3” ) , l t y = c (1 , 1 , 1 ) , lwd = c (3 , 2 , 1 ) )
50 dev . of f ( )
51 }
52
53 #P lo t s s t e p 1 sim times ,
54 stepOne = function (L3 , sim ){
55 pdf ( ”Steg1 . pdf ” )
56 plot (main = ”Step 1 , 9 months ahead” , xlab = ”Time s t ep s ” , ylab = ”LIBOR” ,L3 [ , 1 ] , type = ’ l
’ , yl im = c ( 0 . 0 1 , 0 . 0 3 ) )
57 for ( i in 2 : sim ){
58 l ines (L3 [ , i ] , type = ’ l ’ )
59 }
60 dev . of f ( )
61 }
62
63 stepTwo = function (L2 , sim ){
64 pdf ( ”Steg2 . pdf ” )
65 plot (main = ”Step 2 , 6 months ahead” , xlab = ”Time s t ep s ” , ylab = ”LIBOR” , L2 [ , 1 ] , type = ’
l ’ , ylim = c ( 0 . 0 1 , 0 . 0 3 ) )
66 for ( i in 2 : sim ){
67 l ines (L2 [ , i ] , type = ’ l ’ )
68 }
69 dev . of f ( )
70 }
71
72 stepThree = function (L1 , sim ){
73 pdf ( ” s teg3 . pdf ” )
74 plot (main = ”Step 3 , 3 months ahead” , xlab = ”Time s t ep s ” , ylab = ”LIBOR” , L1 [ , 1 ] , type = ’
l ’ , ylim = c ( 0 . 0 1 , 0 . 0 3 ) )
75 for ( i in 2 : sim ){
76 l ines (L1 [ , i ] , type = ’ l ’ )
77 }
78 dev . of f ( )
79 }
80
81 # m = 1000
82 # The same Brownian motion i s used in a l l o f t h e s t e p s
83 # s t a r t i n g v a l u e s found from b loomberg . com
84 LIBOR3 = function (B T){
85 L 03 = 1.85438/100
86 L3 = rep ( 0 , ( 0 . 7 5∗m) )
87 for ( i in 1 : ( 0 . 7 5∗m) ) {





93 LIBOR2 = function (B T) {
94 L3 = LIBOR3(B T)
95 L 02 = 1.73688/100
96 de l t a = 1/ (4 ) #1/1000?
97 L2 = rep ( 0 , ( 0 . 5∗m) )
98 in t = 0
99 for ( i in 1 : ( 0 . 5∗m) ) {
100 in t = in t + ( (16 . 12/100) ∗ (−( de l t a∗ (16 .05/100)∗L3 [ i ] ) / (1+de l t a∗L3 [ i ] ) ) )
101 }
102 in t = in t / ( 0 . 5∗m)
103 for ( i in 1 : ( 0 . 5∗m) ) {
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109 LIBOR1 = function (B T){
110 L2 = LIBOR2(B T)
111 L3 = LIBOR3(B T)
112 L1 = rep ( 0 , ( 0 . 2 5∗m) )
113 L 01 = 1.50400/100
114 de l t a = 1/ (4 )
115 in t = 0
116 for ( i in 1 : ( 0 . 2 5∗m) ){
117 in t = in t + (16 .19/100) ∗ ((− de l t a ∗ (16 .12/100) ∗ L2 [ i ] ) / (1 + de l t a∗L2 [ i ] ) − ( de l t a
∗ (16 .05/100) ∗ L3 [ i ] ) / (1 + de l t a∗L3 [ i ] ) )
118 }
119 in t = in t/ ( 0 . 25∗m)
120 for ( i in 1 : ( 0 . 2 5∗m) ){




125 E = function ( ) {
126 L1 = 0
127 L2 = 0
128 L3 = 0
129 for ( i in 1 :1000) {
130 L3 = L3 + LIBOR3(b (1000) )
131 L2 = L2 + LIBOR2(b (1000) )
132 L1 = L1 + LIBOR1(b (1000) )
133 }
134 ###OBS! b l a c k = s t e p 1 , red = s t e p 2 , green = s t e p 3
135 pdf ( ” fo rventn ing . pdf ” )
136 plot (main = ”Forventning LIBOR” , xlab = ”Tidss teg ” , ylab = ”LIBOR” , L3/1000 , type = ’ l ’ ,
yl im = c ( 0 . 0 15 , 0 . 0 25 ) )
137 l ines (L2/1000 , type = ’ l ’ , yl im = c ( 0 . 0 25 , 0 . 0 35 ) , col = ’ red ’ )
138 l ines (L1/1000 , type = ’ l ’ , yl im = c ( 0 . 0 25 , 0 . 0 35 ) , col = ’ green ’ )




143 sd = function ( ) {
144 temp = mean(E( ) )/1000
145 sd3 = 0
146 sd3 = sum( (LIBOR3(b (1000) − temp) ˆ2) )
147 return ( (1/1000−1)∗sd3 )
148 }
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